CA2816883A1 - Therapeutic methods and compositions for solid delivery - Google Patents
Therapeutic methods and compositions for solid delivery Download PDFInfo
- Publication number
- CA2816883A1 CA2816883A1 CA2816883A CA2816883A CA2816883A1 CA 2816883 A1 CA2816883 A1 CA 2816883A1 CA 2816883 A CA2816883 A CA 2816883A CA 2816883 A CA2816883 A CA 2816883A CA 2816883 A1 CA2816883 A1 CA 2816883A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- agent
- administration device
- agents
- reporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007787 solid Substances 0.000 title claims description 83
- 239000000203 mixture Substances 0.000 title claims description 45
- 238000002560 therapeutic procedure Methods 0.000 title claims description 16
- 210000001519 tissue Anatomy 0.000 claims abstract description 379
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 333
- 239000003814 drug Substances 0.000 claims abstract description 200
- 239000012530 fluid Substances 0.000 claims abstract description 113
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 111
- 239000000017 hydrogel Substances 0.000 claims abstract description 91
- 229940079593 drug Drugs 0.000 claims abstract description 80
- 230000000694 effects Effects 0.000 claims abstract description 62
- 239000003844 drug implant Substances 0.000 claims abstract description 54
- 238000001727 in vivo Methods 0.000 claims abstract description 28
- 238000011156 evaluation Methods 0.000 claims abstract description 27
- 208000029578 Muscle disease Diseases 0.000 claims abstract description 23
- 238000000151 deposition Methods 0.000 claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims description 377
- 238000000034 method Methods 0.000 claims description 310
- 206010028980 Neoplasm Diseases 0.000 claims description 233
- 108090000623 proteins and genes Proteins 0.000 claims description 150
- 201000011510 cancer Diseases 0.000 claims description 91
- 230000037361 pathway Effects 0.000 claims description 58
- 108010069091 Dystrophin Proteins 0.000 claims description 54
- 230000004044 response Effects 0.000 claims description 52
- 239000008194 pharmaceutical composition Substances 0.000 claims description 49
- 241000282414 Homo sapiens Species 0.000 claims description 48
- 239000011148 porous material Substances 0.000 claims description 48
- 238000003384 imaging method Methods 0.000 claims description 47
- 238000011282 treatment Methods 0.000 claims description 44
- 238000012163 sequencing technique Methods 0.000 claims description 36
- 102000008186 Collagen Human genes 0.000 claims description 33
- 108010035532 Collagen Proteins 0.000 claims description 33
- 229920001436 collagen Polymers 0.000 claims description 33
- 239000000975 dye Substances 0.000 claims description 33
- 230000014509 gene expression Effects 0.000 claims description 32
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 31
- 241001465754 Metazoa Species 0.000 claims description 31
- 230000004913 activation Effects 0.000 claims description 31
- 125000003729 nucleotide group Chemical group 0.000 claims description 30
- 230000019491 signal transduction Effects 0.000 claims description 30
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 230000005764 inhibitory process Effects 0.000 claims description 28
- 229920001223 polyethylene glycol Polymers 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 28
- 239000002202 Polyethylene glycol Substances 0.000 claims description 27
- 238000009792 diffusion process Methods 0.000 claims description 27
- 150000007523 nucleic acids Chemical class 0.000 claims description 26
- 102000004169 proteins and genes Human genes 0.000 claims description 26
- 230000001225 therapeutic effect Effects 0.000 claims description 26
- 210000003205 muscle Anatomy 0.000 claims description 25
- 235000018102 proteins Nutrition 0.000 claims description 25
- 239000003112 inhibitor Substances 0.000 claims description 24
- 102000039446 nucleic acids Human genes 0.000 claims description 24
- 108020004707 nucleic acids Proteins 0.000 claims description 24
- 230000006907 apoptotic process Effects 0.000 claims description 23
- 108010056852 Myostatin Proteins 0.000 claims description 22
- 108060001084 Luciferase Proteins 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 21
- 239000005089 Luciferase Substances 0.000 claims description 20
- 238000004458 analytical method Methods 0.000 claims description 20
- 230000008827 biological function Effects 0.000 claims description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 20
- 230000002068 genetic effect Effects 0.000 claims description 19
- 210000000130 stem cell Anatomy 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 18
- 239000007850 fluorescent dye Substances 0.000 claims description 18
- 239000002246 antineoplastic agent Substances 0.000 claims description 16
- 238000013518 transcription Methods 0.000 claims description 16
- 230000035897 transcription Effects 0.000 claims description 16
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 15
- 239000003623 enhancer Substances 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 13
- 201000009342 Limb-girdle muscular dystrophy Diseases 0.000 claims description 12
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 241000701022 Cytomegalovirus Species 0.000 claims description 11
- 108020004459 Small interfering RNA Proteins 0.000 claims description 11
- 230000000295 complement effect Effects 0.000 claims description 11
- 238000001415 gene therapy Methods 0.000 claims description 11
- 229920001610 polycaprolactone Polymers 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 241000283690 Bos taurus Species 0.000 claims description 10
- 208000021642 Muscular disease Diseases 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 201000006938 muscular dystrophy Diseases 0.000 claims description 10
- 239000004632 polycaprolactone Substances 0.000 claims description 10
- 239000013603 viral vector Substances 0.000 claims description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 9
- 241000702421 Dependoparvovirus Species 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 9
- 102000034287 fluorescent proteins Human genes 0.000 claims description 9
- 108091006047 fluorescent proteins Proteins 0.000 claims description 9
- 230000001939 inductive effect Effects 0.000 claims description 9
- 238000013519 translation Methods 0.000 claims description 9
- 238000012165 high-throughput sequencing Methods 0.000 claims description 8
- 201000000585 muscular atrophy Diseases 0.000 claims description 8
- 210000002027 skeletal muscle Anatomy 0.000 claims description 8
- 239000004055 small Interfering RNA Substances 0.000 claims description 8
- 108020005544 Antisense RNA Proteins 0.000 claims description 7
- 206010028289 Muscle atrophy Diseases 0.000 claims description 7
- 108700008625 Reporter Genes Proteins 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 7
- 230000009849 deactivation Effects 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 238000011068 loading method Methods 0.000 claims description 7
- 210000001087 myotubule Anatomy 0.000 claims description 7
- 239000013642 negative control Substances 0.000 claims description 7
- 230000035790 physiological processes and functions Effects 0.000 claims description 7
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 239000013641 positive control Substances 0.000 claims description 7
- 241001430294 unidentified retrovirus Species 0.000 claims description 7
- 241000713666 Lentivirus Species 0.000 claims description 6
- 108700011259 MicroRNAs Proteins 0.000 claims description 6
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims description 6
- 241000700159 Rattus Species 0.000 claims description 6
- 241000700584 Simplexvirus Species 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 6
- 239000003184 complementary RNA Substances 0.000 claims description 6
- 210000004072 lung Anatomy 0.000 claims description 6
- 239000002679 microRNA Substances 0.000 claims description 6
- 230000001172 regenerating effect Effects 0.000 claims description 6
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 5
- 201000006935 Becker muscular dystrophy Diseases 0.000 claims description 5
- 108090000994 Catalytic RNA Proteins 0.000 claims description 5
- 102000053642 Catalytic RNA Human genes 0.000 claims description 5
- 102000004420 Creatine Kinase Human genes 0.000 claims description 5
- 108010042126 Creatine kinase Proteins 0.000 claims description 5
- 108060008487 Myosin Proteins 0.000 claims description 5
- 210000004504 adult stem cell Anatomy 0.000 claims description 5
- 239000002269 analeptic agent Substances 0.000 claims description 5
- 239000000730 antalgic agent Substances 0.000 claims description 5
- 230000002429 anti-coagulating effect Effects 0.000 claims description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 239000000043 antiallergic agent Substances 0.000 claims description 5
- 229960005475 antiinfective agent Drugs 0.000 claims description 5
- 239000004599 antimicrobial Substances 0.000 claims description 5
- 230000005775 apoptotic pathway Effects 0.000 claims description 5
- 229940000033 dermatological agent Drugs 0.000 claims description 5
- 239000003241 dermatological agent Substances 0.000 claims description 5
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 5
- 230000009368 gene silencing by RNA Effects 0.000 claims description 5
- 230000028993 immune response Effects 0.000 claims description 5
- 239000007927 intramuscular injection Substances 0.000 claims description 5
- 238000010255 intramuscular injection Methods 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 5
- 239000000816 peptidomimetic Substances 0.000 claims description 5
- 239000002096 quantum dot Substances 0.000 claims description 5
- 230000002040 relaxant effect Effects 0.000 claims description 5
- 238000009256 replacement therapy Methods 0.000 claims description 5
- 108091092562 ribozyme Proteins 0.000 claims description 5
- 230000035945 sensitivity Effects 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 5
- 230000002459 sustained effect Effects 0.000 claims description 5
- 241000701161 unidentified adenovirus Species 0.000 claims description 5
- 239000003071 vasodilator agent Substances 0.000 claims description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- 208000029402 Bulbospinal muscular atrophy Diseases 0.000 claims description 4
- 241000283707 Capra Species 0.000 claims description 4
- 241000700199 Cavia porcellus Species 0.000 claims description 4
- 241000699800 Cricetinae Species 0.000 claims description 4
- 241000283073 Equus caballus Species 0.000 claims description 4
- 102000016970 Follistatin Human genes 0.000 claims description 4
- 108010014612 Follistatin Proteins 0.000 claims description 4
- 108010012820 Follistatin-Related Proteins Proteins 0.000 claims description 4
- 101710142641 G-protein coupled receptor-associated sorting protein 1 Proteins 0.000 claims description 4
- 241000699694 Gerbillinae Species 0.000 claims description 4
- 206010061218 Inflammation Diseases 0.000 claims description 4
- 208000027747 Kennedy disease Diseases 0.000 claims description 4
- 102000003505 Myosin Human genes 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 108091008611 Protein Kinase B Proteins 0.000 claims description 4
- 241000282898 Sus scrofa Species 0.000 claims description 4
- 101710160038 WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 Proteins 0.000 claims description 4
- 210000004556 brain Anatomy 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 210000003238 esophagus Anatomy 0.000 claims description 4
- 210000002216 heart Anatomy 0.000 claims description 4
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 4
- 230000004054 inflammatory process Effects 0.000 claims description 4
- 210000000936 intestine Anatomy 0.000 claims description 4
- 210000003734 kidney Anatomy 0.000 claims description 4
- 210000000867 larynx Anatomy 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 claims description 4
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 4
- 108020004999 messenger RNA Proteins 0.000 claims description 4
- 239000013528 metallic particle Substances 0.000 claims description 4
- 210000004165 myocardium Anatomy 0.000 claims description 4
- 239000002405 nuclear magnetic resonance imaging agent Substances 0.000 claims description 4
- 210000001672 ovary Anatomy 0.000 claims description 4
- 210000000496 pancreas Anatomy 0.000 claims description 4
- 238000010647 peptide synthesis reaction Methods 0.000 claims description 4
- 210000002307 prostate Anatomy 0.000 claims description 4
- 208000001076 sarcopenia Diseases 0.000 claims description 4
- 210000000952 spleen Anatomy 0.000 claims description 4
- 210000002784 stomach Anatomy 0.000 claims description 4
- 210000001685 thyroid gland Anatomy 0.000 claims description 4
- 241000701447 unidentified baculovirus Species 0.000 claims description 4
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 claims description 3
- 101000935845 Aliivibrio fischeri Blue fluorescence protein Proteins 0.000 claims description 3
- 108091023037 Aptamer Proteins 0.000 claims description 3
- 208000031229 Cardiomyopathies Diseases 0.000 claims description 3
- 108091005944 Cerulean Proteins 0.000 claims description 3
- 241000579895 Chlorostilbon Species 0.000 claims description 3
- 108091005960 Citrine Proteins 0.000 claims description 3
- 108091005943 CyPet Proteins 0.000 claims description 3
- 206010059866 Drug resistance Diseases 0.000 claims description 3
- 108091005941 EBFP Proteins 0.000 claims description 3
- 108091005942 ECFP Proteins 0.000 claims description 3
- 102100034239 Emerin Human genes 0.000 claims description 3
- 201000009344 Emery-Dreifuss muscular dystrophy Diseases 0.000 claims description 3
- 101000935842 Escherichia coli O127:H6 (strain E2348/69 / EPEC) Major structural subunit of bundle-forming pilus Proteins 0.000 claims description 3
- 108010093031 Galactosidases Proteins 0.000 claims description 3
- 102000002464 Galactosidases Human genes 0.000 claims description 3
- 101001023784 Heteractis crispa GFP-like non-fluorescent chromoprotein Proteins 0.000 claims description 3
- 101000741544 Homo sapiens Properdin Proteins 0.000 claims description 3
- 101001079872 Homo sapiens RING finger protein 112 Proteins 0.000 claims description 3
- 102100022745 Laminin subunit alpha-2 Human genes 0.000 claims description 3
- 201000009110 Oculopharyngeal muscular dystrophy Diseases 0.000 claims description 3
- 102000003992 Peroxidases Human genes 0.000 claims description 3
- 241000545067 Venus Species 0.000 claims description 3
- 239000012829 chemotherapy agent Substances 0.000 claims description 3
- 239000011035 citrine Substances 0.000 claims description 3
- 201000006815 congenital muscular dystrophy Diseases 0.000 claims description 3
- 201000009338 distal myopathy Diseases 0.000 claims description 3
- 239000010976 emerald Substances 0.000 claims description 3
- 229910052876 emerald Inorganic materials 0.000 claims description 3
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 3
- 230000001747 exhibiting effect Effects 0.000 claims description 3
- 108010021843 fluorescent protein 583 Proteins 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000020763 muscle atrophy Effects 0.000 claims description 3
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
- 108010054624 red fluorescent protein Proteins 0.000 claims description 3
- 229910052594 sapphire Inorganic materials 0.000 claims description 3
- 239000010980 sapphire Substances 0.000 claims description 3
- 108091005957 yellow fluorescent proteins Proteins 0.000 claims description 3
- 206010006895 Cachexia Diseases 0.000 claims description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 206010014561 Emphysema Diseases 0.000 claims description 2
- 206010019280 Heart failures Diseases 0.000 claims description 2
- 206010024229 Leprosy Diseases 0.000 claims description 2
- 208000002720 Malnutrition Diseases 0.000 claims description 2
- 101710132081 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Proteins 0.000 claims description 2
- 241000288906 Primates Species 0.000 claims description 2
- 239000000611 antibody drug conjugate Substances 0.000 claims description 2
- 238000009175 antibody therapy Methods 0.000 claims description 2
- 229940049595 antibody-drug conjugate Drugs 0.000 claims description 2
- 208000020832 chronic kidney disease Diseases 0.000 claims description 2
- 208000028208 end stage renal disease Diseases 0.000 claims description 2
- 201000000523 end stage renal failure Diseases 0.000 claims description 2
- 208000017169 kidney disease Diseases 0.000 claims description 2
- 210000002751 lymph Anatomy 0.000 claims description 2
- 230000001071 malnutrition Effects 0.000 claims description 2
- 235000000824 malnutrition Nutrition 0.000 claims description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 claims description 2
- 208000005368 osteomalacia Diseases 0.000 claims description 2
- 210000002460 smooth muscle Anatomy 0.000 claims description 2
- 201000008827 tuberculosis Diseases 0.000 claims description 2
- 102000001039 Dystrophin Human genes 0.000 claims 8
- 102000004472 Myostatin Human genes 0.000 claims 3
- 108091030071 RNAI Proteins 0.000 claims 2
- 102000019203 Follistatin-Related Proteins Human genes 0.000 claims 1
- 102100036001 G-protein coupled receptor-associated sorting protein 1 Human genes 0.000 claims 1
- 241000009328 Perro Species 0.000 claims 1
- 229940068204 drug implant Drugs 0.000 abstract description 9
- 108020004414 DNA Proteins 0.000 description 45
- 239000000463 material Substances 0.000 description 40
- -1 catabolites Substances 0.000 description 39
- 102100024108 Dystrophin Human genes 0.000 description 36
- 230000006870 function Effects 0.000 description 34
- 239000007924 injection Substances 0.000 description 25
- 238000002347 injection Methods 0.000 description 25
- 229940088598 enzyme Drugs 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 19
- 230000001413 cellular effect Effects 0.000 description 18
- 230000003321 amplification Effects 0.000 description 17
- 239000012528 membrane Substances 0.000 description 17
- 238000003199 nucleic acid amplification method Methods 0.000 description 17
- 230000004650 oncogenic pathway Effects 0.000 description 17
- 238000012216 screening Methods 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- 239000007943 implant Substances 0.000 description 16
- 238000003780 insertion Methods 0.000 description 16
- 230000037431 insertion Effects 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 108091026890 Coding region Proteins 0.000 description 15
- 238000010171 animal model Methods 0.000 description 15
- 230000008901 benefit Effects 0.000 description 15
- 239000002585 base Substances 0.000 description 14
- 210000004379 membrane Anatomy 0.000 description 14
- 102000040430 polynucleotide Human genes 0.000 description 14
- 108091033319 polynucleotide Proteins 0.000 description 14
- 239000002157 polynucleotide Substances 0.000 description 14
- 210000002845 virion Anatomy 0.000 description 13
- 239000012071 phase Substances 0.000 description 12
- 239000013607 AAV vector Substances 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 239000011324 bead Substances 0.000 description 10
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000014616 translation Effects 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 108010075653 Utrophin Proteins 0.000 description 9
- 210000000987 immune system Anatomy 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 241000124008 Mammalia Species 0.000 description 8
- 230000027455 binding Effects 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 230000004220 muscle function Effects 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000013334 tissue model Methods 0.000 description 8
- 206010006187 Breast cancer Diseases 0.000 description 7
- 208000026310 Breast neoplasm Diseases 0.000 description 7
- 102100029092 Utrophin Human genes 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 238000010348 incorporation Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 6
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
- 108010059343 MM Form Creatine Kinase Proteins 0.000 description 6
- 201000002481 Myositis Diseases 0.000 description 6
- BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 238000012377 drug delivery Methods 0.000 description 6
- 239000005090 green fluorescent protein Substances 0.000 description 6
- 239000003018 immunosuppressive agent Substances 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 210000004881 tumor cell Anatomy 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 102100029379 Follistatin-related protein 3 Human genes 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 108091027981 Response element Proteins 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 230000033115 angiogenesis Effects 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 238000010874 in vitro model Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000000663 muscle cell Anatomy 0.000 description 5
- 230000007115 recruitment Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 102100039121 Histone-lysine N-methyltransferase MECOM Human genes 0.000 description 4
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 4
- 101001033728 Homo sapiens Histone-lysine N-methyltransferase MECOM Proteins 0.000 description 4
- 206010061598 Immunodeficiency Diseases 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 208000010428 Muscle Weakness Diseases 0.000 description 4
- 206010028372 Muscular weakness Diseases 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 108091007960 PI3Ks Proteins 0.000 description 4
- 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 4
- 230000002942 anti-growth Effects 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 4
- 229960002170 azathioprine Drugs 0.000 description 4
- 108091008324 binding proteins Proteins 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 4
- 201000008275 breast carcinoma Diseases 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000009087 cell motility Effects 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 230000001744 histochemical effect Effects 0.000 description 4
- 229940124589 immunosuppressive drug Drugs 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000007834 ligase chain reaction Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 4
- 229960001428 mercaptopurine Drugs 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 102000016914 ras Proteins Human genes 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 238000002689 xenotransplantation Methods 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000963438 Gaussia <copepod> Species 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 3
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 3
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 3
- 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 3
- 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 3
- 102100036220 PC4 and SFRS1-interacting protein Human genes 0.000 description 3
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 3
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 3
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 3
- 108010083379 Sarcoglycans Proteins 0.000 description 3
- 102000006308 Sarcoglycans Human genes 0.000 description 3
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 3
- 108010019965 Spectrin Proteins 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 3
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 3
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 3
- 102100036021 WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 Human genes 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000002469 basement membrane Anatomy 0.000 description 3
- 230000008236 biological pathway Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000002380 cytological effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000012350 deep sequencing Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000000881 depressing effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 238000013412 genome amplification Methods 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 230000003394 haemopoietic effect Effects 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 238000007491 morphometric analysis Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- UJCHIZDEQZMODR-BYPYZUCNSA-N (2r)-2-acetamido-3-sulfanylpropanamide Chemical compound CC(=O)N[C@@H](CS)C(N)=O UJCHIZDEQZMODR-BYPYZUCNSA-N 0.000 description 2
- KUBDPRSHRVANQQ-NSOVKSMOSA-N (2s,6s)-6-(4-tert-butylphenyl)-2-(4-methylphenyl)-1-(4-methylphenyl)sulfonyl-3,6-dihydro-2h-pyridine-5-carboxylic acid Chemical compound C1=CC(C)=CC=C1[C@H]1N(S(=O)(=O)C=2C=CC(C)=CC=2)[C@@H](C=2C=CC(=CC=2)C(C)(C)C)C(C(O)=O)=CC1 KUBDPRSHRVANQQ-NSOVKSMOSA-N 0.000 description 2
- QYAPHLRPFNSDNH-MRFRVZCGSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-MRFRVZCGSA-N 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical class O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 2
- DIDGPCDGNMIUNX-UUOKFMHZSA-N 2-amino-9-[(2r,3r,4s,5r)-5-(dihydroxyphosphinothioyloxymethyl)-3,4-dihydroxyoxolan-2-yl]-3h-purin-6-one Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=S)[C@@H](O)[C@H]1O DIDGPCDGNMIUNX-UUOKFMHZSA-N 0.000 description 2
- 102100023340 3-ketodihydrosphingosine reductase Human genes 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 102100037685 60S ribosomal protein L22 Human genes 0.000 description 2
- 102100040084 A-kinase anchor protein 9 Human genes 0.000 description 2
- 102100024379 AF4/FMR2 family member 1 Human genes 0.000 description 2
- 102100024387 AF4/FMR2 family member 3 Human genes 0.000 description 2
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 2
- 102100025684 APC membrane recruitment protein 1 Human genes 0.000 description 2
- 102000000872 ATM Human genes 0.000 description 2
- 102100027452 ATP-dependent DNA helicase Q4 Human genes 0.000 description 2
- 102100028247 Abl interactor 1 Human genes 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010059616 Activins Proteins 0.000 description 2
- 102100035886 Adenine DNA glycosylase Human genes 0.000 description 2
- 241000972680 Adeno-associated virus - 6 Species 0.000 description 2
- 208000003200 Adenoma Diseases 0.000 description 2
- 206010001233 Adenoma benign Diseases 0.000 description 2
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 2
- 102100036775 Afadin Human genes 0.000 description 2
- 108010080691 Alcohol O-acetyltransferase Proteins 0.000 description 2
- 101710119858 Alpha-1-acid glycoprotein Proteins 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 240000002022 Anthriscus cerefolium Species 0.000 description 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
- 101100502732 Arabidopsis thaliana FEY gene Proteins 0.000 description 2
- 102100030907 Aryl hydrocarbon receptor nuclear translocator Human genes 0.000 description 2
- 108010004586 Ataxia Telangiectasia Mutated Proteins Proteins 0.000 description 2
- 102100022716 Atypical chemokine receptor 3 Human genes 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 108700024832 B-Cell CLL-Lymphoma 10 Proteins 0.000 description 2
- 108700009171 B-Cell Lymphoma 3 Proteins 0.000 description 2
- 102100021630 B-cell CLL/lymphoma 7 protein family member A Human genes 0.000 description 2
- 102100032481 B-cell CLL/lymphoma 9 protein Human genes 0.000 description 2
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 description 2
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 description 2
- 102100021570 B-cell lymphoma 3 protein Human genes 0.000 description 2
- 102100037598 B-cell lymphoma/leukemia 10 Human genes 0.000 description 2
- 102100022976 B-cell lymphoma/leukemia 11A Human genes 0.000 description 2
- 102100022983 B-cell lymphoma/leukemia 11B Human genes 0.000 description 2
- 101150074953 BCL10 gene Proteins 0.000 description 2
- 108091012583 BCL2 Proteins 0.000 description 2
- 102000036365 BRCA1 Human genes 0.000 description 2
- 108700020463 BRCA1 Proteins 0.000 description 2
- 101150072950 BRCA1 gene Proteins 0.000 description 2
- 108700020462 BRCA2 Proteins 0.000 description 2
- 102000052609 BRCA2 Human genes 0.000 description 2
- 108091005625 BRD4 Proteins 0.000 description 2
- 108700003785 Baculoviral IAP Repeat-Containing 3 Proteins 0.000 description 2
- 102100021662 Baculoviral IAP repeat-containing protein 3 Human genes 0.000 description 2
- 206010004146 Basal cell carcinoma Diseases 0.000 description 2
- 101150072667 Bcl3 gene Proteins 0.000 description 2
- 101150104237 Birc3 gene Proteins 0.000 description 2
- 108010006654 Bleomycin Proteins 0.000 description 2
- 102100035631 Bloom syndrome protein Human genes 0.000 description 2
- 108091009167 Bloom syndrome protein Proteins 0.000 description 2
- 102100025423 Bone morphogenetic protein receptor type-1A Human genes 0.000 description 2
- 101001042041 Bos taurus Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 101150008921 Brca2 gene Proteins 0.000 description 2
- 102100026008 Breakpoint cluster region protein Human genes 0.000 description 2
- 102100033642 Bromodomain-containing protein 3 Human genes 0.000 description 2
- 102100029895 Bromodomain-containing protein 4 Human genes 0.000 description 2
- 101710098191 C-4 methylsterol oxidase ERG25 Proteins 0.000 description 2
- 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 description 2
- 102100033849 CCHC-type zinc finger nucleic acid binding protein Human genes 0.000 description 2
- 108010083123 CDX2 Transcription Factor Proteins 0.000 description 2
- 102100021975 CREB-binding protein Human genes 0.000 description 2
- 102100040775 CREB-regulated transcription coactivator 1 Human genes 0.000 description 2
- 102100040755 CREB-regulated transcription coactivator 3 Human genes 0.000 description 2
- 102100024155 Cadherin-11 Human genes 0.000 description 2
- 101000690445 Caenorhabditis elegans Aryl hydrocarbon receptor nuclear translocator homolog Proteins 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 102100024965 Caspase recruitment domain-containing protein 11 Human genes 0.000 description 2
- 102100028914 Catenin beta-1 Human genes 0.000 description 2
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 2
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 2
- 102000038594 Cdh1/Fizzy-related Human genes 0.000 description 2
- 102100031456 Centriolin Human genes 0.000 description 2
- 102100031203 Centrosomal protein 43 Human genes 0.000 description 2
- 241000867610 Chlorocebus pygerythrus Species 0.000 description 2
- 208000005243 Chondrosarcoma Diseases 0.000 description 2
- 102100026127 Clathrin heavy chain 1 Human genes 0.000 description 2
- 102100034665 Clathrin heavy chain 2 Human genes 0.000 description 2
- 108091033380 Coding strand Proteins 0.000 description 2
- 102100023689 Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 Human genes 0.000 description 2
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 2
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 2
- 108010060313 Core Binding Factor beta Subunit Proteins 0.000 description 2
- 102000008147 Core Binding Factor beta Subunit Human genes 0.000 description 2
- 102100026359 Cyclic AMP-responsive element-binding protein 1 Human genes 0.000 description 2
- 102100039299 Cyclic AMP-responsive element-binding protein 3-like protein 2 Human genes 0.000 description 2
- 108010058546 Cyclin D1 Proteins 0.000 description 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 2
- 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 2
- 108010009367 Cyclin-Dependent Kinase Inhibitor p18 Proteins 0.000 description 2
- 102000009503 Cyclin-Dependent Kinase Inhibitor p18 Human genes 0.000 description 2
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 2
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- 229930105110 Cyclosporin A Natural products 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 2
- 102100030299 Cysteine-rich hydrophobic domain-containing protein 2 Human genes 0.000 description 2
- 102100030115 Cysteine-tRNA ligase, cytoplasmic Human genes 0.000 description 2
- 102100028202 Cytochrome c oxidase subunit 6C Human genes 0.000 description 2
- 102100038497 Cytokine receptor-like factor 2 Human genes 0.000 description 2
- 102100038284 Cytospin-B Human genes 0.000 description 2
- 102100021122 DNA damage-binding protein 2 Human genes 0.000 description 2
- 102100029145 DNA damage-inducible transcript 3 protein Human genes 0.000 description 2
- 102100031866 DNA excision repair protein ERCC-5 Human genes 0.000 description 2
- 108010035476 DNA excision repair protein ERCC-5 Proteins 0.000 description 2
- 108090000133 DNA helicases Proteins 0.000 description 2
- 102000003844 DNA helicases Human genes 0.000 description 2
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 2
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 2
- 102100029094 DNA repair endonuclease XPF Human genes 0.000 description 2
- 102100033934 DNA repair protein RAD51 homolog 2 Human genes 0.000 description 2
- 102100022474 DNA repair protein complementing XP-A cells Human genes 0.000 description 2
- 102100022477 DNA repair protein complementing XP-C cells Human genes 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 102100024607 DNA topoisomerase 1 Human genes 0.000 description 2
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108010092160 Dactinomycin Proteins 0.000 description 2
- 108010086291 Deubiquitinating Enzyme CYLD Proteins 0.000 description 2
- 101100226017 Dictyostelium discoideum repD gene Proteins 0.000 description 2
- 102100034583 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 Human genes 0.000 description 2
- 241001669680 Dormitator maculatus Species 0.000 description 2
- 102100021158 Double homeobox protein 4 Human genes 0.000 description 2
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 2
- 102100035813 E3 ubiquitin-protein ligase CBL Human genes 0.000 description 2
- 102100035273 E3 ubiquitin-protein ligase CBL-B Human genes 0.000 description 2
- 102100035275 E3 ubiquitin-protein ligase CBL-C Human genes 0.000 description 2
- 102100037038 E3 ubiquitin-protein ligase CCNB1IP1 Human genes 0.000 description 2
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 2
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 2
- 102100029505 E3 ubiquitin-protein ligase TRIM33 Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102100038415 ELKS/Rab6-interacting/CAST family member 1 Human genes 0.000 description 2
- 101150105460 ERCC2 gene Proteins 0.000 description 2
- 102100023792 ETS domain-containing protein Elk-4 Human genes 0.000 description 2
- 102100039563 ETS translocation variant 1 Human genes 0.000 description 2
- 102100039578 ETS translocation variant 4 Human genes 0.000 description 2
- 102100039577 ETS translocation variant 5 Human genes 0.000 description 2
- 102100039247 ETS-related transcription factor Elf-4 Human genes 0.000 description 2
- 102100027100 Echinoderm microtubule-associated protein-like 4 Human genes 0.000 description 2
- 102100028401 Endophilin-A2 Human genes 0.000 description 2
- 102100023387 Endoribonuclease Dicer Human genes 0.000 description 2
- 102100031785 Endothelial transcription factor GATA-2 Human genes 0.000 description 2
- 102100039369 Epidermal growth factor receptor substrate 15 Human genes 0.000 description 2
- 102100031690 Erythroid transcription factor Human genes 0.000 description 2
- 102100022462 Eukaryotic initiation factor 4A-II Human genes 0.000 description 2
- 102100029055 Exostosin-1 Human genes 0.000 description 2
- 102100029074 Exostosin-2 Human genes 0.000 description 2
- 101710105178 F-box/WD repeat-containing protein 7 Proteins 0.000 description 2
- 102100028138 F-box/WD repeat-containing protein 7 Human genes 0.000 description 2
- 102000009095 Fanconi Anemia Complementation Group A protein Human genes 0.000 description 2
- 108010087740 Fanconi Anemia Complementation Group A protein Proteins 0.000 description 2
- 102000018825 Fanconi Anemia Complementation Group C protein Human genes 0.000 description 2
- 108010027673 Fanconi Anemia Complementation Group C protein Proteins 0.000 description 2
- 102000013601 Fanconi Anemia Complementation Group D2 protein Human genes 0.000 description 2
- 108010026653 Fanconi Anemia Complementation Group D2 protein Proteins 0.000 description 2
- 102000010634 Fanconi Anemia Complementation Group E protein Human genes 0.000 description 2
- 108010077898 Fanconi Anemia Complementation Group E protein Proteins 0.000 description 2
- 102000012216 Fanconi Anemia Complementation Group F protein Human genes 0.000 description 2
- 108010022012 Fanconi Anemia Complementation Group F protein Proteins 0.000 description 2
- 102000007122 Fanconi Anemia Complementation Group G protein Human genes 0.000 description 2
- 108010033305 Fanconi Anemia Complementation Group G protein Proteins 0.000 description 2
- 108010067741 Fanconi Anemia Complementation Group N protein Proteins 0.000 description 2
- 102100034553 Fanconi anemia group J protein Human genes 0.000 description 2
- 102100034334 Fatty acid CoA ligase Acsl3 Human genes 0.000 description 2
- 102100031513 Fc receptor-like protein 4 Human genes 0.000 description 2
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 2
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 2
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 2
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 2
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 2
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 2
- 201000008808 Fibrosarcoma Diseases 0.000 description 2
- 102100027909 Folliculin Human genes 0.000 description 2
- 108010010285 Forkhead Box Protein L2 Proteins 0.000 description 2
- 102100035137 Forkhead box protein L2 Human genes 0.000 description 2
- 102100035416 Forkhead box protein O4 Human genes 0.000 description 2
- 102100028122 Forkhead box protein P1 Human genes 0.000 description 2
- 102100040680 Formin-binding protein 1 Human genes 0.000 description 2
- 102100030334 Friend leukemia integration 1 transcription factor Human genes 0.000 description 2
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 2
- 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 2
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 description 2
- 102100033452 GMP synthase [glutamine-hydrolyzing] Human genes 0.000 description 2
- 101710071060 GMPS Proteins 0.000 description 2
- 102100029974 GTPase HRas Human genes 0.000 description 2
- 102100030708 GTPase KRas Human genes 0.000 description 2
- 102100039788 GTPase NRas Human genes 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 101001077417 Gallus gallus Potassium voltage-gated channel subfamily H member 6 Proteins 0.000 description 2
- 102100031885 General transcription and DNA repair factor IIH helicase subunit XPB Human genes 0.000 description 2
- 102100035184 General transcription and DNA repair factor IIH helicase subunit XPD Human genes 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 102100033295 Glial cell line-derived neurotrophic factor Human genes 0.000 description 2
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102100025960 Glutaminase kidney isoform, mitochondrial Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102100032530 Glypican-3 Human genes 0.000 description 2
- 102100036675 Golgi-associated PDZ and coiled-coil motif-containing protein Human genes 0.000 description 2
- 102100041032 Golgin subfamily A member 5 Human genes 0.000 description 2
- 241000282575 Gorilla Species 0.000 description 2
- 102100031493 Growth arrest-specific protein 7 Human genes 0.000 description 2
- 102100025334 Guanine nucleotide-binding protein G(q) subunit alpha Human genes 0.000 description 2
- 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 description 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 2
- 108700039143 HMGA2 Proteins 0.000 description 2
- 102100031561 Hamartin Human genes 0.000 description 2
- 102100028789 Heat shock protein HSP 90-alpha A2 Human genes 0.000 description 2
- 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 102100024001 Hepatic leukemia factor Human genes 0.000 description 2
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 2
- 102100035616 Heterogeneous nuclear ribonucleoproteins A2/B1 Human genes 0.000 description 2
- 102100035108 High affinity nerve growth factor receptor Human genes 0.000 description 2
- 102100029009 High mobility group protein HMG-I/HMG-Y Human genes 0.000 description 2
- 102100028999 High mobility group protein HMGI-C Human genes 0.000 description 2
- 102100034523 Histone H4 Human genes 0.000 description 2
- 102100033071 Histone acetyltransferase KAT6A Human genes 0.000 description 2
- 102100033070 Histone acetyltransferase KAT6B Human genes 0.000 description 2
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 description 2
- 102100022103 Histone-lysine N-methyltransferase 2A Human genes 0.000 description 2
- 102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 description 2
- 102100029234 Histone-lysine N-methyltransferase NSD2 Human genes 0.000 description 2
- 102100029235 Histone-lysine N-methyltransferase NSD3 Human genes 0.000 description 2
- 102100024594 Histone-lysine N-methyltransferase PRDM16 Human genes 0.000 description 2
- 102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 2
- 102100029239 Histone-lysine N-methyltransferase, H3 lysine-36 specific Human genes 0.000 description 2
- 101150073387 Hmga2 gene Proteins 0.000 description 2
- 102100031671 Homeobox protein CDX-2 Human genes 0.000 description 2
- 102100030308 Homeobox protein Hox-A11 Human genes 0.000 description 2
- 102100030307 Homeobox protein Hox-A13 Human genes 0.000 description 2
- 102100021090 Homeobox protein Hox-A9 Human genes 0.000 description 2
- 102100020766 Homeobox protein Hox-C11 Human genes 0.000 description 2
- 102100020761 Homeobox protein Hox-C13 Human genes 0.000 description 2
- 102100039545 Homeobox protein Hox-D11 Human genes 0.000 description 2
- 102100040227 Homeobox protein Hox-D13 Human genes 0.000 description 2
- 101000590272 Homo sapiens 26S proteasome non-ATPase regulatory subunit 2 Proteins 0.000 description 2
- 101001050680 Homo sapiens 3-ketodihydrosphingosine reductase Proteins 0.000 description 2
- 101001097555 Homo sapiens 60S ribosomal protein L22 Proteins 0.000 description 2
- 101000890598 Homo sapiens A-kinase anchor protein 9 Proteins 0.000 description 2
- 101000833180 Homo sapiens AF4/FMR2 family member 1 Proteins 0.000 description 2
- 101000833166 Homo sapiens AF4/FMR2 family member 3 Proteins 0.000 description 2
- 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 description 2
- 101000719162 Homo sapiens APC membrane recruitment protein 1 Proteins 0.000 description 2
- 101000580577 Homo sapiens ATP-dependent DNA helicase Q4 Proteins 0.000 description 2
- 101000724225 Homo sapiens Abl interactor 1 Proteins 0.000 description 2
- 101001000351 Homo sapiens Adenine DNA glycosylase Proteins 0.000 description 2
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 2
- 101000928246 Homo sapiens Afadin Proteins 0.000 description 2
- 101000793115 Homo sapiens Aryl hydrocarbon receptor nuclear translocator Proteins 0.000 description 2
- 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 description 2
- 101000971230 Homo sapiens B-cell CLL/lymphoma 7 protein family member A Proteins 0.000 description 2
- 101000798495 Homo sapiens B-cell CLL/lymphoma 9 protein Proteins 0.000 description 2
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 description 2
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 description 2
- 101000903703 Homo sapiens B-cell lymphoma/leukemia 11A Proteins 0.000 description 2
- 101000903697 Homo sapiens B-cell lymphoma/leukemia 11B Proteins 0.000 description 2
- 101000934638 Homo sapiens Bone morphogenetic protein receptor type-1A Proteins 0.000 description 2
- 101000933320 Homo sapiens Breakpoint cluster region protein Proteins 0.000 description 2
- 101000871851 Homo sapiens Bromodomain-containing protein 3 Proteins 0.000 description 2
- 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 description 2
- 101000710837 Homo sapiens CCHC-type zinc finger nucleic acid binding protein Proteins 0.000 description 2
- 101000896987 Homo sapiens CREB-binding protein Proteins 0.000 description 2
- 101000891939 Homo sapiens CREB-regulated transcription coactivator 1 Proteins 0.000 description 2
- 101000891906 Homo sapiens CREB-regulated transcription coactivator 3 Proteins 0.000 description 2
- 101000762236 Homo sapiens Cadherin-11 Proteins 0.000 description 2
- 101000761179 Homo sapiens Caspase recruitment domain-containing protein 11 Proteins 0.000 description 2
- 101000916173 Homo sapiens Catenin beta-1 Proteins 0.000 description 2
- 101000762448 Homo sapiens Cdc42 effector protein 1 Proteins 0.000 description 2
- 101000941711 Homo sapiens Centriolin Proteins 0.000 description 2
- 101000776477 Homo sapiens Centrosomal protein 43 Proteins 0.000 description 2
- 101000912851 Homo sapiens Clathrin heavy chain 1 Proteins 0.000 description 2
- 101000946482 Homo sapiens Clathrin heavy chain 2 Proteins 0.000 description 2
- 101000906984 Homo sapiens Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 Proteins 0.000 description 2
- 101000711004 Homo sapiens Cx9C motif-containing protein 4 Proteins 0.000 description 2
- 101000855516 Homo sapiens Cyclic AMP-responsive element-binding protein 1 Proteins 0.000 description 2
- 101000745624 Homo sapiens Cyclic AMP-responsive element-binding protein 3-like protein 2 Proteins 0.000 description 2
- 101000991100 Homo sapiens Cysteine-rich hydrophobic domain-containing protein 2 Proteins 0.000 description 2
- 101000586290 Homo sapiens Cysteine-tRNA ligase, cytoplasmic Proteins 0.000 description 2
- 101000861049 Homo sapiens Cytochrome c oxidase subunit 6C Proteins 0.000 description 2
- 101000956427 Homo sapiens Cytokine receptor-like factor 2 Proteins 0.000 description 2
- 101000884817 Homo sapiens Cytospin-B Proteins 0.000 description 2
- 101001041466 Homo sapiens DNA damage-binding protein 2 Proteins 0.000 description 2
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 2
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 2
- 101001132307 Homo sapiens DNA repair protein RAD51 homolog 2 Proteins 0.000 description 2
- 101000618531 Homo sapiens DNA repair protein complementing XP-A cells Proteins 0.000 description 2
- 101000618535 Homo sapiens DNA repair protein complementing XP-C cells Proteins 0.000 description 2
- 101000830681 Homo sapiens DNA topoisomerase 1 Proteins 0.000 description 2
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 2
- 101000848781 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 Proteins 0.000 description 2
- 101000968549 Homo sapiens Double homeobox protein 4 Proteins 0.000 description 2
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 description 2
- 101000737265 Homo sapiens E3 ubiquitin-protein ligase CBL-B Proteins 0.000 description 2
- 101000737269 Homo sapiens E3 ubiquitin-protein ligase CBL-C Proteins 0.000 description 2
- 101000737896 Homo sapiens E3 ubiquitin-protein ligase CCNB1IP1 Proteins 0.000 description 2
- 101000634991 Homo sapiens E3 ubiquitin-protein ligase TRIM33 Proteins 0.000 description 2
- 101001100208 Homo sapiens ELKS/Rab6-interacting/CAST family member 1 Proteins 0.000 description 2
- 101001048716 Homo sapiens ETS domain-containing protein Elk-4 Proteins 0.000 description 2
- 101000813729 Homo sapiens ETS translocation variant 1 Proteins 0.000 description 2
- 101000813747 Homo sapiens ETS translocation variant 4 Proteins 0.000 description 2
- 101000813745 Homo sapiens ETS translocation variant 5 Proteins 0.000 description 2
- 101000813135 Homo sapiens ETS-related transcription factor Elf-4 Proteins 0.000 description 2
- 101001057929 Homo sapiens Echinoderm microtubule-associated protein-like 4 Proteins 0.000 description 2
- 101000851054 Homo sapiens Elastin Proteins 0.000 description 2
- 101000632553 Homo sapiens Endophilin-A2 Proteins 0.000 description 2
- 101000907904 Homo sapiens Endoribonuclease Dicer Proteins 0.000 description 2
- 101001066265 Homo sapiens Endothelial transcription factor GATA-2 Proteins 0.000 description 2
- 101000967216 Homo sapiens Eosinophil cationic protein Proteins 0.000 description 2
- 101000812517 Homo sapiens Epidermal growth factor receptor substrate 15 Proteins 0.000 description 2
- 101001066268 Homo sapiens Erythroid transcription factor Proteins 0.000 description 2
- 101001044475 Homo sapiens Eukaryotic initiation factor 4A-II Proteins 0.000 description 2
- 101000918311 Homo sapiens Exostosin-1 Proteins 0.000 description 2
- 101000918275 Homo sapiens Exostosin-2 Proteins 0.000 description 2
- 101000848171 Homo sapiens Fanconi anemia group J protein Proteins 0.000 description 2
- 101000780194 Homo sapiens Fatty acid CoA ligase Acsl3 Proteins 0.000 description 2
- 101000846909 Homo sapiens Fc receptor-like protein 4 Proteins 0.000 description 2
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 2
- 101001060703 Homo sapiens Folliculin Proteins 0.000 description 2
- 101001062529 Homo sapiens Follistatin-related protein 3 Proteins 0.000 description 2
- 101000877683 Homo sapiens Forkhead box protein O4 Proteins 0.000 description 2
- 101001059893 Homo sapiens Forkhead box protein P1 Proteins 0.000 description 2
- 101000892722 Homo sapiens Formin-binding protein 1 Proteins 0.000 description 2
- 101001062996 Homo sapiens Friend leukemia integration 1 transcription factor Proteins 0.000 description 2
- 101000980741 Homo sapiens G1/S-specific cyclin-D2 Proteins 0.000 description 2
- 101000738559 Homo sapiens G1/S-specific cyclin-D3 Proteins 0.000 description 2
- 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 2
- 101000584612 Homo sapiens GTPase KRas Proteins 0.000 description 2
- 101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 2
- 101000920748 Homo sapiens General transcription and DNA repair factor IIH helicase subunit XPB Proteins 0.000 description 2
- 101000856990 Homo sapiens Glutaminase kidney isoform, mitochondrial Proteins 0.000 description 2
- 101001014668 Homo sapiens Glypican-3 Proteins 0.000 description 2
- 101001072499 Homo sapiens Golgi-associated PDZ and coiled-coil motif-containing protein Proteins 0.000 description 2
- 101001039330 Homo sapiens Golgin subfamily A member 5 Proteins 0.000 description 2
- 101000923044 Homo sapiens Growth arrest-specific protein 7 Proteins 0.000 description 2
- 101000857888 Homo sapiens Guanine nucleotide-binding protein G(q) subunit alpha Proteins 0.000 description 2
- 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 description 2
- 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 description 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 2
- 101000795643 Homo sapiens Hamartin Proteins 0.000 description 2
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 2
- 101001078626 Homo sapiens Heat shock protein HSP 90-alpha A2 Proteins 0.000 description 2
- 101001016856 Homo sapiens Heat shock protein HSP 90-beta Proteins 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 description 2
- 101000854026 Homo sapiens Heterogeneous nuclear ribonucleoproteins A2/B1 Proteins 0.000 description 2
- 101000596894 Homo sapiens High affinity nerve growth factor receptor Proteins 0.000 description 2
- 101000986380 Homo sapiens High mobility group protein HMG-I/HMG-Y Proteins 0.000 description 2
- 101001067880 Homo sapiens Histone H4 Proteins 0.000 description 2
- 101000944179 Homo sapiens Histone acetyltransferase KAT6A Proteins 0.000 description 2
- 101000944174 Homo sapiens Histone acetyltransferase KAT6B Proteins 0.000 description 2
- 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 description 2
- 101001045846 Homo sapiens Histone-lysine N-methyltransferase 2A Proteins 0.000 description 2
- 101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 description 2
- 101000634048 Homo sapiens Histone-lysine N-methyltransferase NSD2 Proteins 0.000 description 2
- 101000634046 Homo sapiens Histone-lysine N-methyltransferase NSD3 Proteins 0.000 description 2
- 101000686942 Homo sapiens Histone-lysine N-methyltransferase PRDM16 Proteins 0.000 description 2
- 101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 2
- 101000634050 Homo sapiens Histone-lysine N-methyltransferase, H3 lysine-36 specific Proteins 0.000 description 2
- 101001083158 Homo sapiens Homeobox protein Hox-A11 Proteins 0.000 description 2
- 101001003015 Homo sapiens Homeobox protein Hox-C11 Proteins 0.000 description 2
- 101001002988 Homo sapiens Homeobox protein Hox-C13 Proteins 0.000 description 2
- 101000962591 Homo sapiens Homeobox protein Hox-D11 Proteins 0.000 description 2
- 101001037168 Homo sapiens Homeobox protein Hox-D13 Proteins 0.000 description 2
- 101001035137 Homo sapiens Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein Proteins 0.000 description 2
- 101001021527 Homo sapiens Huntingtin-interacting protein 1 Proteins 0.000 description 2
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 2
- 101001011441 Homo sapiens Interferon regulatory factor 4 Proteins 0.000 description 2
- 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 description 2
- 101000960234 Homo sapiens Isocitrate dehydrogenase [NADP] cytoplasmic Proteins 0.000 description 2
- 101000599886 Homo sapiens Isocitrate dehydrogenase [NADP], mitochondrial Proteins 0.000 description 2
- 101000605528 Homo sapiens Kallikrein-2 Proteins 0.000 description 2
- 101001090172 Homo sapiens Kinectin Proteins 0.000 description 2
- 101000971521 Homo sapiens Kinetochore scaffold 1 Proteins 0.000 description 2
- 101000981546 Homo sapiens LHFPL tetraspan subfamily member 6 protein Proteins 0.000 description 2
- 101001023330 Homo sapiens LIM and SH3 domain protein 1 Proteins 0.000 description 2
- 101001042362 Homo sapiens Leukemia inhibitory factor receptor Proteins 0.000 description 2
- 101001003687 Homo sapiens Lipoma-preferred partner Proteins 0.000 description 2
- 101001064870 Homo sapiens Lon protease homolog, mitochondrial Proteins 0.000 description 2
- 101000780202 Homo sapiens Long-chain-fatty-acid-CoA ligase 6 Proteins 0.000 description 2
- 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 2
- 101001088892 Homo sapiens Lysine-specific demethylase 5A Proteins 0.000 description 2
- 101001088887 Homo sapiens Lysine-specific demethylase 5C Proteins 0.000 description 2
- 101001025967 Homo sapiens Lysine-specific demethylase 6A Proteins 0.000 description 2
- 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 description 2
- 101000763322 Homo sapiens M1-specific T cell receptor beta chain Proteins 0.000 description 2
- 101000983747 Homo sapiens MHC class II transactivator Proteins 0.000 description 2
- 101001005667 Homo sapiens Mastermind-like protein 2 Proteins 0.000 description 2
- 101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 description 2
- 101000582631 Homo sapiens Menin Proteins 0.000 description 2
- 101000954986 Homo sapiens Merlin Proteins 0.000 description 2
- 101000581507 Homo sapiens Methyl-CpG-binding domain protein 1 Proteins 0.000 description 2
- 101000653360 Homo sapiens Methylcytosine dioxygenase TET1 Proteins 0.000 description 2
- 101000653374 Homo sapiens Methylcytosine dioxygenase TET2 Proteins 0.000 description 2
- 101000794228 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 beta Proteins 0.000 description 2
- 101000987094 Homo sapiens Moesin Proteins 0.000 description 2
- 101001074975 Homo sapiens Molybdopterin molybdenumtransferase Proteins 0.000 description 2
- 101000576323 Homo sapiens Motor neuron and pancreas homeobox protein 1 Proteins 0.000 description 2
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 2
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 2
- 101001056394 Homo sapiens Myelodysplastic syndrome 2 translocation-associated protein Proteins 0.000 description 2
- 101001013158 Homo sapiens Myeloid leukemia factor 1 Proteins 0.000 description 2
- 101000591286 Homo sapiens Myocardin-related transcription factor A Proteins 0.000 description 2
- 101000589016 Homo sapiens Myomegalin Proteins 0.000 description 2
- 101001000104 Homo sapiens Myosin-11 Proteins 0.000 description 2
- 101001030232 Homo sapiens Myosin-9 Proteins 0.000 description 2
- 101000906927 Homo sapiens N-chimaerin Proteins 0.000 description 2
- 101001128138 Homo sapiens NACHT, LRR and PYD domains-containing protein 2 Proteins 0.000 description 2
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 2
- 101001122114 Homo sapiens NUT family member 1 Proteins 0.000 description 2
- 101000588247 Homo sapiens Nascent polypeptide-associated complex subunit alpha Proteins 0.000 description 2
- 101000981973 Homo sapiens Nascent polypeptide-associated complex subunit alpha, muscle-specific form Proteins 0.000 description 2
- 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 description 2
- 101000981336 Homo sapiens Nibrin Proteins 0.000 description 2
- 101000979497 Homo sapiens Ninein Proteins 0.000 description 2
- 101000578287 Homo sapiens Non-POU domain-containing octamer-binding protein Proteins 0.000 description 2
- 101000973211 Homo sapiens Nuclear factor 1 B-type Proteins 0.000 description 2
- 101000979338 Homo sapiens Nuclear factor NF-kappa-B p100 subunit Proteins 0.000 description 2
- 101000598160 Homo sapiens Nuclear mitotic apparatus protein 1 Proteins 0.000 description 2
- 101000996563 Homo sapiens Nuclear pore complex protein Nup214 Proteins 0.000 description 2
- 101000602926 Homo sapiens Nuclear receptor coactivator 1 Proteins 0.000 description 2
- 101000602930 Homo sapiens Nuclear receptor coactivator 2 Proteins 0.000 description 2
- 101000974343 Homo sapiens Nuclear receptor coactivator 4 Proteins 0.000 description 2
- 101001109689 Homo sapiens Nuclear receptor subfamily 4 group A member 3 Proteins 0.000 description 2
- 101001109719 Homo sapiens Nucleophosmin Proteins 0.000 description 2
- 101000801664 Homo sapiens Nucleoprotein TPR Proteins 0.000 description 2
- 101000986810 Homo sapiens P2Y purinoceptor 8 Proteins 0.000 description 2
- 101000736088 Homo sapiens PC4 and SFRS1-interacting protein Proteins 0.000 description 2
- 101000738901 Homo sapiens PMS1 protein homolog 1 Proteins 0.000 description 2
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
- 101001072590 Homo sapiens POZ-, AT hook-, and zinc finger-containing protein 1 Proteins 0.000 description 2
- 101000613490 Homo sapiens Paired box protein Pax-3 Proteins 0.000 description 2
- 101000601724 Homo sapiens Paired box protein Pax-5 Proteins 0.000 description 2
- 101000601661 Homo sapiens Paired box protein Pax-7 Proteins 0.000 description 2
- 101000601664 Homo sapiens Paired box protein Pax-8 Proteins 0.000 description 2
- 101001069727 Homo sapiens Paired mesoderm homeobox protein 1 Proteins 0.000 description 2
- 101000692768 Homo sapiens Paired mesoderm homeobox protein 2B Proteins 0.000 description 2
- 101000945735 Homo sapiens Parafibromin Proteins 0.000 description 2
- 101000987581 Homo sapiens Perforin-1 Proteins 0.000 description 2
- 101001134861 Homo sapiens Pericentriolar material 1 protein Proteins 0.000 description 2
- 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 description 2
- 101001120056 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit alpha Proteins 0.000 description 2
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 2
- 101000583474 Homo sapiens Phosphatidylinositol-binding clathrin assembly protein Proteins 0.000 description 2
- 101000596046 Homo sapiens Plastin-2 Proteins 0.000 description 2
- 101000609360 Homo sapiens Platelet-activating factor acetylhydrolase IB subunit alpha2 Proteins 0.000 description 2
- 101000728236 Homo sapiens Polycomb group protein ASXL1 Proteins 0.000 description 2
- 101000584499 Homo sapiens Polycomb protein SUZ12 Proteins 0.000 description 2
- 101000906619 Homo sapiens Polyribonucleotide 5'-hydroxyl-kinase Clp1 Proteins 0.000 description 2
- 101000610107 Homo sapiens Pre-B-cell leukemia transcription factor 1 Proteins 0.000 description 2
- 101000846284 Homo sapiens Pre-mRNA 3'-end-processing factor FIP1 Proteins 0.000 description 2
- 101000720856 Homo sapiens Probable ATP-dependent RNA helicase DDX10 Proteins 0.000 description 2
- 101000952113 Homo sapiens Probable ATP-dependent RNA helicase DDX5 Proteins 0.000 description 2
- 101000919019 Homo sapiens Probable ATP-dependent RNA helicase DDX6 Proteins 0.000 description 2
- 101000611614 Homo sapiens Proline-rich protein PRCC Proteins 0.000 description 2
- 101001098872 Homo sapiens Proprotein convertase subtilisin/kexin type 7 Proteins 0.000 description 2
- 101000718497 Homo sapiens Protein AF-10 Proteins 0.000 description 2
- 101000892360 Homo sapiens Protein AF-17 Proteins 0.000 description 2
- 101000959489 Homo sapiens Protein AF-9 Proteins 0.000 description 2
- 101000892338 Homo sapiens Protein AF1q Proteins 0.000 description 2
- 101000797903 Homo sapiens Protein ALEX Proteins 0.000 description 2
- 101000933601 Homo sapiens Protein BTG1 Proteins 0.000 description 2
- 101001116548 Homo sapiens Protein CBFA2T1 Proteins 0.000 description 2
- 101001132819 Homo sapiens Protein CBFA2T3 Proteins 0.000 description 2
- 101000912957 Homo sapiens Protein DEK Proteins 0.000 description 2
- 101000925651 Homo sapiens Protein ENL Proteins 0.000 description 2
- 101000866633 Homo sapiens Protein Hook homolog 3 Proteins 0.000 description 2
- 101000585703 Homo sapiens Protein L-Myc Proteins 0.000 description 2
- 101000573199 Homo sapiens Protein PML Proteins 0.000 description 2
- 101000880769 Homo sapiens Protein SSX1 Proteins 0.000 description 2
- 101000642815 Homo sapiens Protein SSXT Proteins 0.000 description 2
- 101000800847 Homo sapiens Protein TFG Proteins 0.000 description 2
- 101000883014 Homo sapiens Protein capicua homolog Proteins 0.000 description 2
- 101000893493 Homo sapiens Protein flightless-1 homolog Proteins 0.000 description 2
- 101000958299 Homo sapiens Protein lyl-1 Proteins 0.000 description 2
- 101001014035 Homo sapiens Protein p13 MTCP-1 Proteins 0.000 description 2
- 101000695187 Homo sapiens Protein patched homolog 1 Proteins 0.000 description 2
- 101001123332 Homo sapiens Proteoglycan 4 Proteins 0.000 description 2
- 101000686031 Homo sapiens Proto-oncogene tyrosine-protein kinase ROS Proteins 0.000 description 2
- 101000579425 Homo sapiens Proto-oncogene tyrosine-protein kinase receptor Ret Proteins 0.000 description 2
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 2
- 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 description 2
- 101000712530 Homo sapiens RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 2
- 101001048695 Homo sapiens RNA polymerase II elongation factor ELL Proteins 0.000 description 2
- 101001062093 Homo sapiens RNA-binding protein 15 Proteins 0.000 description 2
- 101001130290 Homo sapiens Rab GTPase-binding effector protein 1 Proteins 0.000 description 2
- 101001111814 Homo sapiens Ran-binding protein 17 Proteins 0.000 description 2
- 101000926086 Homo sapiens Rap1 GTPase-GDP dissociation stimulator 1 Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 101000742859 Homo sapiens Retinoblastoma-associated protein Proteins 0.000 description 2
- 101001112293 Homo sapiens Retinoic acid receptor alpha Proteins 0.000 description 2
- 101001091984 Homo sapiens Rho GTPase-activating protein 26 Proteins 0.000 description 2
- 101000927774 Homo sapiens Rho guanine nucleotide exchange factor 12 Proteins 0.000 description 2
- 101000666634 Homo sapiens Rho-related GTP-binding protein RhoH Proteins 0.000 description 2
- 101000631899 Homo sapiens Ribosome maturation protein SBDS Proteins 0.000 description 2
- 101000697544 Homo sapiens SCL-interrupting locus protein Proteins 0.000 description 2
- 101000650863 Homo sapiens SH2 domain-containing protein 1A Proteins 0.000 description 2
- 101000654740 Homo sapiens Septin-5 Proteins 0.000 description 2
- 101000632314 Homo sapiens Septin-6 Proteins 0.000 description 2
- 101000632056 Homo sapiens Septin-9 Proteins 0.000 description 2
- 101000587434 Homo sapiens Serine/arginine-rich splicing factor 3 Proteins 0.000 description 2
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 description 2
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 2
- 101000628562 Homo sapiens Serine/threonine-protein kinase STK11 Proteins 0.000 description 2
- 101000595531 Homo sapiens Serine/threonine-protein kinase pim-1 Proteins 0.000 description 2
- 101000687673 Homo sapiens Small integral membrane protein 6 Proteins 0.000 description 2
- 101000910249 Homo sapiens Soluble calcium-activated nucleotidase 1 Proteins 0.000 description 2
- 101000951145 Homo sapiens Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial Proteins 0.000 description 2
- 101000874160 Homo sapiens Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial Proteins 0.000 description 2
- 101000654245 Homo sapiens Succinate dehydrogenase assembly factor 2, mitochondrial Proteins 0.000 description 2
- 101000934888 Homo sapiens Succinate dehydrogenase cytochrome b560 subunit, mitochondrial Proteins 0.000 description 2
- 101000628885 Homo sapiens Suppressor of fused homolog Proteins 0.000 description 2
- 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 description 2
- 101000763321 Homo sapiens T cell receptor beta chain MC.7.G5 Proteins 0.000 description 2
- 101000891113 Homo sapiens T-cell acute lymphocytic leukemia protein 1 Proteins 0.000 description 2
- 101000625330 Homo sapiens T-cell acute lymphocytic leukemia protein 2 Proteins 0.000 description 2
- 101000800488 Homo sapiens T-cell leukemia homeobox protein 1 Proteins 0.000 description 2
- 101000655119 Homo sapiens T-cell leukemia homeobox protein 3 Proteins 0.000 description 2
- 101000837401 Homo sapiens T-cell leukemia/lymphoma protein 1A Proteins 0.000 description 2
- 101001099181 Homo sapiens TATA-binding protein-associated factor 2N Proteins 0.000 description 2
- 101000835082 Homo sapiens TCF3 fusion partner Proteins 0.000 description 2
- 101000762938 Homo sapiens TOX high mobility group box family member 4 Proteins 0.000 description 2
- 101000728490 Homo sapiens Tether containing UBX domain for GLUT4 Proteins 0.000 description 2
- 101000799466 Homo sapiens Thrombopoietin receptor Proteins 0.000 description 2
- 101000795185 Homo sapiens Thyroid hormone receptor-associated protein 3 Proteins 0.000 description 2
- 101000649022 Homo sapiens Thyroid receptor-interacting protein 11 Proteins 0.000 description 2
- 101000772267 Homo sapiens Thyrotropin receptor Proteins 0.000 description 2
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 2
- 101000702545 Homo sapiens Transcription activator BRG1 Proteins 0.000 description 2
- 101000835720 Homo sapiens Transcription elongation factor A protein 1 Proteins 0.000 description 2
- 101001041525 Homo sapiens Transcription factor 12 Proteins 0.000 description 2
- 101000596772 Homo sapiens Transcription factor 7-like 1 Proteins 0.000 description 2
- 101000666382 Homo sapiens Transcription factor E2-alpha Proteins 0.000 description 2
- 101000837845 Homo sapiens Transcription factor E3 Proteins 0.000 description 2
- 101000837841 Homo sapiens Transcription factor EB Proteins 0.000 description 2
- 101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 description 2
- 101000962461 Homo sapiens Transcription factor Maf Proteins 0.000 description 2
- 101000979190 Homo sapiens Transcription factor MafB Proteins 0.000 description 2
- 101001051166 Homo sapiens Transcriptional activator MN1 Proteins 0.000 description 2
- 101000636213 Homo sapiens Transcriptional activator Myb Proteins 0.000 description 2
- 101001010792 Homo sapiens Transcriptional regulator ERG Proteins 0.000 description 2
- 101000638154 Homo sapiens Transmembrane protease serine 2 Proteins 0.000 description 2
- 101000850794 Homo sapiens Tropomyosin alpha-3 chain Proteins 0.000 description 2
- 101000830781 Homo sapiens Tropomyosin alpha-4 chain Proteins 0.000 description 2
- 101000795659 Homo sapiens Tuberin Proteins 0.000 description 2
- 101000801255 Homo sapiens Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 2
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 2
- 101000733249 Homo sapiens Tumor suppressor ARF Proteins 0.000 description 2
- 101000823316 Homo sapiens Tyrosine-protein kinase ABL1 Proteins 0.000 description 2
- 101000823271 Homo sapiens Tyrosine-protein kinase ABL2 Proteins 0.000 description 2
- 101001050476 Homo sapiens Tyrosine-protein kinase ITK/TSK Proteins 0.000 description 2
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 description 2
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 2
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 2
- 101001047681 Homo sapiens Tyrosine-protein kinase Lck Proteins 0.000 description 2
- 101000604583 Homo sapiens Tyrosine-protein kinase SYK Proteins 0.000 description 2
- 101001087416 Homo sapiens Tyrosine-protein phosphatase non-receptor type 11 Proteins 0.000 description 2
- 101000643895 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 6 Proteins 0.000 description 2
- 101000804798 Homo sapiens Werner syndrome ATP-dependent helicase Proteins 0.000 description 2
- 101000788669 Homo sapiens Zinc finger MYM-type protein 2 Proteins 0.000 description 2
- 101000964425 Homo sapiens Zinc finger and BTB domain-containing protein 16 Proteins 0.000 description 2
- 101000760207 Homo sapiens Zinc finger protein 331 Proteins 0.000 description 2
- 101000964718 Homo sapiens Zinc finger protein 384 Proteins 0.000 description 2
- 101000785690 Homo sapiens Zinc finger protein 521 Proteins 0.000 description 2
- 101000691578 Homo sapiens Zinc finger protein PLAG1 Proteins 0.000 description 2
- 101000634977 Homo sapiens Zinc finger protein RFP Proteins 0.000 description 2
- 101001026573 Homo sapiens cAMP-dependent protein kinase type I-alpha regulatory subunit Proteins 0.000 description 2
- 102100039923 Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein Human genes 0.000 description 2
- 241000701027 Human herpesvirus 6 Species 0.000 description 2
- 102100035957 Huntingtin-interacting protein 1 Human genes 0.000 description 2
- 108010007666 IMP cyclohydrolase Proteins 0.000 description 2
- 102000000521 Immunophilins Human genes 0.000 description 2
- 108010016648 Immunophilins Proteins 0.000 description 2
- 102100026818 Inhibin beta E chain Human genes 0.000 description 2
- 102100020796 Inosine 5'-monophosphate cyclohydrolase Human genes 0.000 description 2
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 2
- 102100030126 Interferon regulatory factor 4 Human genes 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 108010017411 Interleukin-21 Receptors Proteins 0.000 description 2
- 102100030699 Interleukin-21 receptor Human genes 0.000 description 2
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 2
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
- 102100039905 Isocitrate dehydrogenase [NADP] cytoplasmic Human genes 0.000 description 2
- 102100037845 Isocitrate dehydrogenase [NADP], mitochondrial Human genes 0.000 description 2
- 101710029140 KIAA1549 Proteins 0.000 description 2
- 102100038356 Kallikrein-2 Human genes 0.000 description 2
- 102100034751 Kinectin Human genes 0.000 description 2
- 102100021464 Kinetochore scaffold 1 Human genes 0.000 description 2
- 102100020679 Krueppel-like factor 6 Human genes 0.000 description 2
- 108010049058 Kruppel-Like Factor 6 Proteins 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 102100024116 LHFPL tetraspan subfamily member 6 protein Human genes 0.000 description 2
- 102100035118 LIM and SH3 domain protein 1 Human genes 0.000 description 2
- 102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 2
- 102100026358 Lipoma-preferred partner Human genes 0.000 description 2
- 102100034337 Long-chain-fatty-acid-CoA ligase 6 Human genes 0.000 description 2
- 102100029205 Low affinity immunoglobulin gamma Fc region receptor II-b Human genes 0.000 description 2
- 108090000362 Lymphotoxin-beta Proteins 0.000 description 2
- 102100033246 Lysine-specific demethylase 5A Human genes 0.000 description 2
- 102100033249 Lysine-specific demethylase 5C Human genes 0.000 description 2
- 102100037462 Lysine-specific demethylase 6A Human genes 0.000 description 2
- 101150113681 MALT1 gene Proteins 0.000 description 2
- 102000017274 MDM4 Human genes 0.000 description 2
- 108050005300 MDM4 Proteins 0.000 description 2
- 102100026371 MHC class II transactivator Human genes 0.000 description 2
- 229910015837 MSH2 Inorganic materials 0.000 description 2
- 108700012912 MYCN Proteins 0.000 description 2
- 101150022024 MYCN gene Proteins 0.000 description 2
- 241000282553 Macaca Species 0.000 description 2
- 102100025130 Mastermind-like protein 2 Human genes 0.000 description 2
- 102100022430 Melanocyte protein PMEL Human genes 0.000 description 2
- 102100030550 Menin Human genes 0.000 description 2
- 102100037106 Merlin Human genes 0.000 description 2
- 102100027383 Methyl-CpG-binding domain protein 1 Human genes 0.000 description 2
- 102100030819 Methylcytosine dioxygenase TET1 Human genes 0.000 description 2
- 102100030803 Methylcytosine dioxygenase TET2 Human genes 0.000 description 2
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 2
- 102100030157 Microphthalmia-associated transcription factor Human genes 0.000 description 2
- 108010074346 Mismatch Repair Endonuclease PMS2 Proteins 0.000 description 2
- 102000008071 Mismatch Repair Endonuclease PMS2 Human genes 0.000 description 2
- 102100030144 Mitotic checkpoint serine/threonine-protein kinase BUB1 beta Human genes 0.000 description 2
- 102100027869 Moesin Human genes 0.000 description 2
- 241000713869 Moloney murine leukemia virus Species 0.000 description 2
- 102100035971 Molybdopterin molybdenumtransferase Human genes 0.000 description 2
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 2
- 102100025170 Motor neuron and pancreas homeobox protein 1 Human genes 0.000 description 2
- 102100034256 Mucin-1 Human genes 0.000 description 2
- 108700026676 Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Proteins 0.000 description 2
- 102100038732 Mucosa-associated lymphoid tissue lymphoma translocation protein 1 Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000013609 MutL Protein Homolog 1 Human genes 0.000 description 2
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 description 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
- 101000891671 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Medium/long-chain-fatty-acid-CoA ligase FadD6 Proteins 0.000 description 2
- 102100026313 Myelodysplastic syndrome 2 translocation-associated protein Human genes 0.000 description 2
- 102100029691 Myeloid leukemia factor 1 Human genes 0.000 description 2
- 102100034099 Myocardin-related transcription factor A Human genes 0.000 description 2
- 102100032966 Myomegalin Human genes 0.000 description 2
- 102100036639 Myosin-11 Human genes 0.000 description 2
- 102100038938 Myosin-9 Human genes 0.000 description 2
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 2
- 102100023648 N-chimaerin Human genes 0.000 description 2
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 description 2
- 102100027673 NCK-interacting protein with SH3 domain Human genes 0.000 description 2
- 102100029166 NT-3 growth factor receptor Human genes 0.000 description 2
- 102100027086 NUT family member 1 Human genes 0.000 description 2
- 101000783469 Naja kaouthia Tryptophan-containing weak neurotoxin Proteins 0.000 description 2
- 102100026779 Nascent polypeptide-associated complex subunit alpha, muscle-specific form Human genes 0.000 description 2
- 102000007530 Neurofibromin 1 Human genes 0.000 description 2
- 108010085793 Neurofibromin 1 Proteins 0.000 description 2
- 102100024403 Nibrin Human genes 0.000 description 2
- 102100023121 Ninein Human genes 0.000 description 2
- 102100028102 Non-POU domain-containing octamer-binding protein Human genes 0.000 description 2
- 102000001759 Notch1 Receptor Human genes 0.000 description 2
- 108010029755 Notch1 Receptor Proteins 0.000 description 2
- 102000001756 Notch2 Receptor Human genes 0.000 description 2
- 108010029751 Notch2 Receptor Proteins 0.000 description 2
- 102100022165 Nuclear factor 1 B-type Human genes 0.000 description 2
- 102100023059 Nuclear factor NF-kappa-B p100 subunit Human genes 0.000 description 2
- 102100036961 Nuclear mitotic apparatus protein 1 Human genes 0.000 description 2
- 102100033819 Nuclear pore complex protein Nup214 Human genes 0.000 description 2
- 102100025372 Nuclear pore complex protein Nup98-Nup96 Human genes 0.000 description 2
- 102100037223 Nuclear receptor coactivator 1 Human genes 0.000 description 2
- 102100037226 Nuclear receptor coactivator 2 Human genes 0.000 description 2
- 102100022927 Nuclear receptor coactivator 4 Human genes 0.000 description 2
- 102100022673 Nuclear receptor subfamily 4 group A member 3 Human genes 0.000 description 2
- 102100022678 Nucleophosmin Human genes 0.000 description 2
- 102100033615 Nucleoprotein TPR Human genes 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- 102100026747 Osteomodulin Human genes 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 102100028069 P2Y purinoceptor 8 Human genes 0.000 description 2
- 102100037482 PMS1 protein homolog 1 Human genes 0.000 description 2
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 2
- 108060006456 POU2AF1 Proteins 0.000 description 2
- 102000036938 POU2AF1 Human genes 0.000 description 2
- 102100036665 POZ-, AT hook-, and zinc finger-containing protein 1 Human genes 0.000 description 2
- 108010047613 PTB-Associated Splicing Factor Proteins 0.000 description 2
- 102100040891 Paired box protein Pax-3 Human genes 0.000 description 2
- 102100037504 Paired box protein Pax-5 Human genes 0.000 description 2
- 102100037503 Paired box protein Pax-7 Human genes 0.000 description 2
- 102100037502 Paired box protein Pax-8 Human genes 0.000 description 2
- 102100033786 Paired mesoderm homeobox protein 1 Human genes 0.000 description 2
- 102100026354 Paired mesoderm homeobox protein 2B Human genes 0.000 description 2
- 241000282577 Pan troglodytes Species 0.000 description 2
- 241001504519 Papio ursinus Species 0.000 description 2
- 102100034743 Parafibromin Human genes 0.000 description 2
- 102100040884 Partner and localizer of BRCA2 Human genes 0.000 description 2
- 102100028467 Perforin-1 Human genes 0.000 description 2
- 102000017795 Perilipin-1 Human genes 0.000 description 2
- 108010067162 Perilipin-1 Proteins 0.000 description 2
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 2
- 102100026169 Phosphatidylinositol 3-kinase regulatory subunit alpha Human genes 0.000 description 2
- 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 2
- 102100031014 Phosphatidylinositol-binding clathrin assembly protein Human genes 0.000 description 2
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 2
- 102100039449 Platelet-activating factor acetylhydrolase IB subunit alpha2 Human genes 0.000 description 2
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 2
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 description 2
- 102100029799 Polycomb group protein ASXL1 Human genes 0.000 description 2
- 102100030702 Polycomb protein SUZ12 Human genes 0.000 description 2
- 102100023504 Polyribonucleotide 5'-hydroxyl-kinase Clp1 Human genes 0.000 description 2
- 241000282405 Pongo abelii Species 0.000 description 2
- 102100022807 Potassium voltage-gated channel subfamily H member 2 Human genes 0.000 description 2
- 102100040171 Pre-B-cell leukemia transcription factor 1 Human genes 0.000 description 2
- 102100031755 Pre-mRNA 3'-end-processing factor FIP1 Human genes 0.000 description 2
- 102100025897 Probable ATP-dependent RNA helicase DDX10 Human genes 0.000 description 2
- 102100037434 Probable ATP-dependent RNA helicase DDX5 Human genes 0.000 description 2
- 102100029480 Probable ATP-dependent RNA helicase DDX6 Human genes 0.000 description 2
- 102100040829 Proline-rich protein PRCC Human genes 0.000 description 2
- 102100038950 Proprotein convertase subtilisin/kexin type 7 Human genes 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 102100026286 Protein AF-10 Human genes 0.000 description 2
- 102100040638 Protein AF-17 Human genes 0.000 description 2
- 102100039686 Protein AF-9 Human genes 0.000 description 2
- 102100040665 Protein AF1q Human genes 0.000 description 2
- 102100026036 Protein BTG1 Human genes 0.000 description 2
- 102100024952 Protein CBFA2T1 Human genes 0.000 description 2
- 102100033812 Protein CBFA2T3 Human genes 0.000 description 2
- 102100026113 Protein DEK Human genes 0.000 description 2
- 102100033813 Protein ENL Human genes 0.000 description 2
- 102100031717 Protein Hook homolog 3 Human genes 0.000 description 2
- 102100030128 Protein L-Myc Human genes 0.000 description 2
- 102100026375 Protein PML Human genes 0.000 description 2
- 102100037687 Protein SSX1 Human genes 0.000 description 2
- 102100035586 Protein SSXT Human genes 0.000 description 2
- 102100033661 Protein TFG Human genes 0.000 description 2
- 102100038777 Protein capicua homolog Human genes 0.000 description 2
- 102100038231 Protein lyl-1 Human genes 0.000 description 2
- 102100031352 Protein p13 MTCP-1 Human genes 0.000 description 2
- 102100028680 Protein patched homolog 1 Human genes 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 102000016611 Proteoglycans Human genes 0.000 description 2
- 108010019674 Proto-Oncogene Proteins c-sis Proteins 0.000 description 2
- 102100023347 Proto-oncogene tyrosine-protein kinase ROS Human genes 0.000 description 2
- 102100028286 Proto-oncogene tyrosine-protein kinase receptor Ret Human genes 0.000 description 2
- 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 description 2
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 2
- 102100023449 RNA polymerase II elongation factor ELL Human genes 0.000 description 2
- 102100029244 RNA-binding protein 15 Human genes 0.000 description 2
- 108090000740 RNA-binding protein EWS Proteins 0.000 description 2
- 102000004229 RNA-binding protein EWS Human genes 0.000 description 2
- 102000003890 RNA-binding protein FUS Human genes 0.000 description 2
- 108090000292 RNA-binding protein FUS Proteins 0.000 description 2
- 102100031523 Rab GTPase-binding effector protein 1 Human genes 0.000 description 2
- 102100023857 Ran-binding protein 17 Human genes 0.000 description 2
- 102100034329 Rap1 GTPase-GDP dissociation stimulator 1 Human genes 0.000 description 2
- 101000613608 Rattus norvegicus Monocyte to macrophage differentiation factor Proteins 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- 102100038042 Retinoblastoma-associated protein Human genes 0.000 description 2
- 102100023606 Retinoic acid receptor alpha Human genes 0.000 description 2
- 102100035744 Rho GTPase-activating protein 26 Human genes 0.000 description 2
- 102100033193 Rho guanine nucleotide exchange factor 12 Human genes 0.000 description 2
- 102100038338 Rho-related GTP-binding protein RhoH Human genes 0.000 description 2
- 102100028750 Ribosome maturation protein SBDS Human genes 0.000 description 2
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 2
- 238000011579 SCID mouse model Methods 0.000 description 2
- 102100037375 SLIT-ROBO Rho GTPase-activating protein 3 Human genes 0.000 description 2
- 101150019443 SMAD4 gene Proteins 0.000 description 2
- 108700028341 SMARCB1 Proteins 0.000 description 2
- 101150008214 SMARCB1 gene Proteins 0.000 description 2
- 101150083405 SRGAP3 gene Proteins 0.000 description 2
- 102100025746 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 Human genes 0.000 description 2
- 101100379220 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) API2 gene Proteins 0.000 description 2
- 101000702553 Schistosoma mansoni Antigen Sm21.7 Proteins 0.000 description 2
- 101000714192 Schistosoma mansoni Tegument antigen Proteins 0.000 description 2
- 102100032744 Septin-5 Human genes 0.000 description 2
- 102100027982 Septin-6 Human genes 0.000 description 2
- 102100028024 Septin-9 Human genes 0.000 description 2
- 102100029665 Serine/arginine-rich splicing factor 3 Human genes 0.000 description 2
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 description 2
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 2
- 102100026715 Serine/threonine-protein kinase STK11 Human genes 0.000 description 2
- 102100036077 Serine/threonine-protein kinase pim-1 Human genes 0.000 description 2
- 108700031298 Smad4 Proteins 0.000 description 2
- 102100024806 Small integral membrane protein 6 Human genes 0.000 description 2
- 102000013380 Smoothened Receptor Human genes 0.000 description 2
- 101710090597 Smoothened homolog Proteins 0.000 description 2
- 101150045565 Socs1 gene Proteins 0.000 description 2
- 102100024397 Soluble calcium-activated nucleotidase 1 Human genes 0.000 description 2
- 102100027780 Splicing factor, proline- and glutamine-rich Human genes 0.000 description 2
- 102100038014 Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial Human genes 0.000 description 2
- 102100035726 Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial Human genes 0.000 description 2
- 102100031715 Succinate dehydrogenase assembly factor 2, mitochondrial Human genes 0.000 description 2
- 102100025393 Succinate dehydrogenase cytochrome b560 subunit, mitochondrial Human genes 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108010022348 Sulfate adenylyltransferase Proteins 0.000 description 2
- 108700027336 Suppressor of Cytokine Signaling 1 Proteins 0.000 description 2
- 102100024779 Suppressor of cytokine signaling 1 Human genes 0.000 description 2
- 102100026939 Suppressor of fused homolog Human genes 0.000 description 2
- 102100029454 T cell receptor alpha chain MC.7.G5 Human genes 0.000 description 2
- 102100026967 T cell receptor beta chain MC.7.G5 Human genes 0.000 description 2
- 102100040365 T-cell acute lymphocytic leukemia protein 1 Human genes 0.000 description 2
- 102100025039 T-cell acute lymphocytic leukemia protein 2 Human genes 0.000 description 2
- 102100033111 T-cell leukemia homeobox protein 1 Human genes 0.000 description 2
- 102100032568 T-cell leukemia homeobox protein 3 Human genes 0.000 description 2
- 102100028676 T-cell leukemia/lymphoma protein 1A Human genes 0.000 description 2
- 102100026140 TCF3 fusion partner Human genes 0.000 description 2
- 102100026749 TOX high mobility group box family member 4 Human genes 0.000 description 2
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 2
- 102100029773 Tether containing UBX domain for GLUT4 Human genes 0.000 description 2
- 241000906446 Theraps Species 0.000 description 2
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
- 102100034196 Thrombopoietin receptor Human genes 0.000 description 2
- 102100029689 Thyroid hormone receptor-associated protein 3 Human genes 0.000 description 2
- 102100028094 Thyroid receptor-interacting protein 11 Human genes 0.000 description 2
- 102100029337 Thyrotropin receptor Human genes 0.000 description 2
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 2
- 108010057666 Transcription Factor CHOP Proteins 0.000 description 2
- 102100031027 Transcription activator BRG1 Human genes 0.000 description 2
- 102100026430 Transcription elongation factor A protein 1 Human genes 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 102100021123 Transcription factor 12 Human genes 0.000 description 2
- 102100038313 Transcription factor E2-alpha Human genes 0.000 description 2
- 102100028507 Transcription factor E3 Human genes 0.000 description 2
- 102100028502 Transcription factor EB Human genes 0.000 description 2
- 102100039580 Transcription factor ETV6 Human genes 0.000 description 2
- 102100039189 Transcription factor Maf Human genes 0.000 description 2
- 102100023234 Transcription factor MafB Human genes 0.000 description 2
- 102100025171 Transcription initiation factor TFIID subunit 12 Human genes 0.000 description 2
- 102100022011 Transcription intermediary factor 1-alpha Human genes 0.000 description 2
- 102100024592 Transcriptional activator MN1 Human genes 0.000 description 2
- 102100030780 Transcriptional activator Myb Human genes 0.000 description 2
- 102100031989 Transmembrane protease serine 2 Human genes 0.000 description 2
- 102100033080 Tropomyosin alpha-3 chain Human genes 0.000 description 2
- 102100024944 Tropomyosin alpha-4 chain Human genes 0.000 description 2
- 102100031638 Tuberin Human genes 0.000 description 2
- 108010047933 Tumor Necrosis Factor alpha-Induced Protein 3 Proteins 0.000 description 2
- 108010079351 Tumor Suppressor Protein p14ARF Proteins 0.000 description 2
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 2
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 2
- 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 2
- 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 2
- 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 2
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 description 2
- 102100022651 Tyrosine-protein kinase ABL2 Human genes 0.000 description 2
- 102100023345 Tyrosine-protein kinase ITK/TSK Human genes 0.000 description 2
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 description 2
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 2
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 2
- 102100024036 Tyrosine-protein kinase Lck Human genes 0.000 description 2
- 102100038183 Tyrosine-protein kinase SYK Human genes 0.000 description 2
- 102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 description 2
- 102100022865 UPF0606 protein KIAA1549 Human genes 0.000 description 2
- 102100021015 Ubiquitin carboxyl-terminal hydrolase 6 Human genes 0.000 description 2
- 102100024250 Ubiquitin carboxyl-terminal hydrolase CYLD Human genes 0.000 description 2
- 102000040856 WT1 Human genes 0.000 description 2
- 108700020467 WT1 Proteins 0.000 description 2
- 101150084041 WT1 gene Proteins 0.000 description 2
- 102100035336 Werner syndrome ATP-dependent helicase Human genes 0.000 description 2
- 108700031763 Xeroderma Pigmentosum Group D Proteins 0.000 description 2
- 102100025085 Zinc finger MYM-type protein 2 Human genes 0.000 description 2
- 102100040314 Zinc finger and BTB domain-containing protein 16 Human genes 0.000 description 2
- 102100024661 Zinc finger protein 331 Human genes 0.000 description 2
- 102100040731 Zinc finger protein 384 Human genes 0.000 description 2
- 102100026302 Zinc finger protein 521 Human genes 0.000 description 2
- 102100026200 Zinc finger protein PLAG1 Human genes 0.000 description 2
- 102100029504 Zinc finger protein RFP Human genes 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
- 229940045799 anthracyclines and related substance Drugs 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 229940045686 antimetabolites antineoplastic purine analogs Drugs 0.000 description 2
- 229940045687 antimetabolites folic acid analogs Drugs 0.000 description 2
- 239000003972 antineoplastic antibiotic Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000011717 athymic nude mouse Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 229960001561 bleomycin Drugs 0.000 description 2
- 102100037490 cAMP-dependent protein kinase type I-alpha regulatory subunit Human genes 0.000 description 2
- 229940046731 calcineurin inhibitors Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000033077 cellular process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940044683 chemotherapy drug Drugs 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000000562 conjugate Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- 230000003436 cytoskeletal effect Effects 0.000 description 2
- 210000004292 cytoskeleton Anatomy 0.000 description 2
- 239000000824 cytostatic agent Substances 0.000 description 2
- 230000001085 cytostatic effect Effects 0.000 description 2
- 229960000640 dactinomycin Drugs 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 108010018033 endothelial PAS domain-containing protein 1 Proteins 0.000 description 2
- 230000007247 enzymatic mechanism Effects 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- 230000000925 erythroid effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960000556 fingolimod Drugs 0.000 description 2
- KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 description 2
- 150000002224 folic acids Chemical class 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical group C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000003197 gene knockdown Methods 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 108010021685 homeobox protein HOXA13 Proteins 0.000 description 2
- 108010027263 homeobox protein HOXA9 Proteins 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000000984 immunochemical effect Effects 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 229940125721 immunosuppressive agent Drugs 0.000 description 2
- 238000012606 in vitro cell culture Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229940047124 interferons Drugs 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 201000005296 lung carcinoma Diseases 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 2
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 229940014456 mycophenolate Drugs 0.000 description 2
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000008634 non enzymatic mechanism Effects 0.000 description 2
- 108010054452 nuclear pore complex protein 98 Proteins 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000002747 omentum Anatomy 0.000 description 2
- 230000006712 oncogenic signaling pathway Effects 0.000 description 2
- 229940005483 opioid analgesics Drugs 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229960003171 plicamycin Drugs 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 208000005987 polymyositis Diseases 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 229940124606 potential therapeutic agent Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- 108010014186 ras Proteins Proteins 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000007841 sequencing by ligation Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- 208000000649 small cell carcinoma Diseases 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 description 2
- 229960001967 tacrolimus Drugs 0.000 description 2
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- 108010071511 transcriptional intermediary factor 1 Proteins 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 108010064892 trkC Receptor Proteins 0.000 description 2
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 2
- 208000010576 undifferentiated carcinoma Diseases 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 229960005289 voclosporin Drugs 0.000 description 2
- 108010057559 voclosporin Proteins 0.000 description 2
- BICRTLVBTLFLRD-PTWUADNWSA-N voclosporin Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O BICRTLVBTLFLRD-PTWUADNWSA-N 0.000 description 2
- 108010073629 xeroderma pigmentosum group F protein Proteins 0.000 description 2
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
- HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 102100032157 Adenylate cyclase type 10 Human genes 0.000 description 1
- 102100040149 Adenylyl-sulfate kinase Human genes 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 108010007730 Apyrase Proteins 0.000 description 1
- 102000007347 Apyrase Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 1
- 102100024210 CD166 antigen Human genes 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 102100022002 CD59 glycoprotein Human genes 0.000 description 1
- 102100035350 CUB domain-containing protein 1 Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical class C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- 102100025682 Dystroglycan 1 Human genes 0.000 description 1
- 108010071885 Dystroglycans Proteins 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108090000852 Forkhead Transcription Factors Proteins 0.000 description 1
- 102000004315 Forkhead Transcription Factors Human genes 0.000 description 1
- 101150093612 GAP43 gene Proteins 0.000 description 1
- 102000001267 GSK3 Human genes 0.000 description 1
- 108060006662 GSK3 Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 102000053171 Glial Fibrillary Acidic Human genes 0.000 description 1
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000775498 Homo sapiens Adenylate cyclase type 10 Proteins 0.000 description 1
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
- 101000737742 Homo sapiens CUB domain-containing protein 1 Proteins 0.000 description 1
- 101001053946 Homo sapiens Dystrophin Proteins 0.000 description 1
- 101000843809 Homo sapiens Hydroxycarboxylic acid receptor 2 Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 101001008953 Homo sapiens Kinesin-like protein KIF11 Proteins 0.000 description 1
- 101001057159 Homo sapiens Melanoma-associated antigen C3 Proteins 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
- 101001074035 Homo sapiens Zinc finger protein GLI2 Proteins 0.000 description 1
- 241001135569 Human adenovirus 5 Species 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102100027629 Kinesin-like protein KIF11 Human genes 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000289581 Macropus sp. Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
- 101100369076 Mus musculus Tdgf1 gene Proteins 0.000 description 1
- 102000047918 Myelin Basic Human genes 0.000 description 1
- 101710107068 Myelin basic protein Proteins 0.000 description 1
- 102100031790 Myelin expression factor 2 Human genes 0.000 description 1
- 101710107751 Myelin expression factor 2 Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 102000008730 Nestin Human genes 0.000 description 1
- 108010088225 Nestin Proteins 0.000 description 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
- 101100058191 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) bcp-1 gene Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920000432 Polylactide-block-poly(ethylene glycol)-block-polylactide Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101710150114 Protein rep Proteins 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 108010052090 Renilla Luciferases Proteins 0.000 description 1
- 241001068295 Replication defective viruses Species 0.000 description 1
- 101710152114 Replication protein Proteins 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 102220497176 Small vasohibin-binding protein_T47D_mutation Human genes 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000004523 Sulfate Adenylyltransferase Human genes 0.000 description 1
- 108090001076 Synaptophysin Proteins 0.000 description 1
- 102000004874 Synaptophysin Human genes 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
- 208000010399 Wasting Syndrome Diseases 0.000 description 1
- 102100035558 Zinc finger protein GLI2 Human genes 0.000 description 1
- VSYMNDBTCKIDLT-UHFFFAOYSA-N [2-(carbamoyloxymethyl)-2-ethylbutyl] carbamate Chemical compound NC(=O)OCC(CC)(CC)COC(N)=O VSYMNDBTCKIDLT-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- XJSPKZQCRWULFD-UHFFFAOYSA-N acetic acid;2-amino-2-ethylbutanoic acid Chemical compound CC(O)=O.CCC(N)(CC)C(O)=O XJSPKZQCRWULFD-UHFFFAOYSA-N 0.000 description 1
- 210000001361 achilles tendon Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- IRLPACMLTUPBCL-FCIPNVEPSA-N adenosine-5'-phosphosulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO[P@](O)(=O)OS(O)(=O)=O)[C@H](O)[C@H]1O IRLPACMLTUPBCL-FCIPNVEPSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229910002056 binary alloy Inorganic materials 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920000229 biodegradable polyester Polymers 0.000 description 1
- 239000004622 biodegradable polyester Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000000453 cell autonomous effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical class O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000037020 contractile activity Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- JQZRVMZHTADUSY-UHFFFAOYSA-L di(octanoyloxy)tin Chemical compound [Sn+2].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O JQZRVMZHTADUSY-UHFFFAOYSA-L 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000009699 differential effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 108060002894 fibrillar collagen Proteins 0.000 description 1
- 102000013373 fibrillar collagen Human genes 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229960002584 gefitinib Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000007849 hot-start PCR Methods 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 229940036998 hypertonic sodium chloride Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000012750 in vivo screening Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 102000043253 matrix Gla protein Human genes 0.000 description 1
- 108010057546 matrix Gla protein Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 238000001964 muscle biopsy Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 101150042523 myod gene Proteins 0.000 description 1
- ROYXIPOUVGDTAO-UHFFFAOYSA-N n-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-amine Chemical compound C1=CC(OCC)=CC=C1NC1=NC(C=2N3C=CC=CC3=NC=2C)=CS1 ROYXIPOUVGDTAO-UHFFFAOYSA-N 0.000 description 1
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 210000005055 nestin Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 1
- 230000009437 off-target effect Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000003068 pathway analysis Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 230000009038 pharmacological inhibition Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 108060006184 phycobiliprotein Proteins 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 102000004401 podocalyxin Human genes 0.000 description 1
- 108090000917 podocalyxin Proteins 0.000 description 1
- 229920001553 poly(ethylene glycol)-block-polylactide methyl ether Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 108010057417 polysialyl neural cell adhesion molecule Proteins 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000004777 protein coat Anatomy 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000013608 rAAV vector Substances 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 101150066583 rep gene Proteins 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 238000007860 single-cell PCR Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940043517 specific immunoglobulins Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013269 sustained drug release Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000002446 thrombocytic effect Effects 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 210000003014 totipotent stem cell Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1407—Infusion of two or more substances
- A61M5/1408—Infusion of two or more substances in parallel, e.g. manifolds, sequencing valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3295—Multiple needle devices, e.g. a plurality of needles arranged coaxially or in parallel
- A61M5/3298—Needles arranged in parallel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41668610P | 2010-11-23 | 2010-11-23 | |
| US61/416,686 | 2010-11-23 | ||
| US41715710P | 2010-11-24 | 2010-11-24 | |
| US61/417,157 | 2010-11-24 | ||
| US201161454115P | 2011-03-18 | 2011-03-18 | |
| US61/454,115 | 2011-03-18 | ||
| US201161475594P | 2011-04-14 | 2011-04-14 | |
| US61/475,594 | 2011-04-14 | ||
| US201161475858P | 2011-04-15 | 2011-04-15 | |
| US61/475,858 | 2011-04-15 | ||
| US201161483437P | 2011-05-06 | 2011-05-06 | |
| US61/483,437 | 2011-05-06 | ||
| PCT/US2011/062128 WO2012071559A2 (en) | 2010-11-23 | 2011-11-23 | Therapeutic methods and compositions for solid delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2816883A1 true CA2816883A1 (en) | 2012-05-31 |
Family
ID=46146433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2816883A Abandoned CA2816883A1 (en) | 2010-11-23 | 2011-11-23 | Therapeutic methods and compositions for solid delivery |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20140114279A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2767298A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2013544600A (cg-RX-API-DMAC7.html) |
| CN (2) | CN103492016A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011332815A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2816883A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012071559A2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016101069A1 (en) * | 2014-12-23 | 2016-06-30 | Atkinson Cole Michael Joseph | Multiple needle assembly |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE035598T2 (en) | 2008-12-02 | 2018-05-28 | Allergan Inc | Injection device |
| CA2689400C (en) * | 2009-12-30 | 2023-01-10 | Kenneth W. Adams | Therapeutic agent delivery apparatus and process |
| AU2012328457A1 (en) | 2011-10-28 | 2014-04-24 | Presage Biosciences, Inc. | Methods for drug delivery |
| SG11201500937UA (en) * | 2012-08-08 | 2015-03-30 | Presage Biosciences Inc | Extrusion methods and devices for drug delivery |
| DK2959294T3 (en) * | 2013-02-25 | 2018-11-19 | Imabiotech | PROCEDURE FOR EVALUATING THE TISSUE TARGETING OF A MOLECULE OF INTEREST |
| US20140350516A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Mechanical syringe accessory |
| US20140350518A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Syringe extrusion accessory |
| US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
| RU2602452C2 (ru) * | 2014-05-14 | 2016-11-20 | Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук | Способ выявления веществ и их композиций с противоопухолевой активностью |
| CA2959130A1 (en) * | 2014-08-11 | 2016-02-18 | The Board Of Regents Of The University Of Texas System | Prevention of muscular dystrophy by crispr/cas9-mediated gene editing |
| GB201414464D0 (en) | 2014-08-14 | 2014-10-01 | Technion Res & Dev Foundation | Compositions and methods for therapeutics prescreening |
| KR101636775B1 (ko) * | 2014-08-19 | 2016-07-08 | 아주대학교산학협력단 | 부위마취 장치 및 방법 |
| US10226585B2 (en) | 2014-10-01 | 2019-03-12 | Allergan, Inc. | Devices for injection and dosing |
| CN104483321B (zh) | 2014-10-31 | 2017-07-28 | 苏州捷碧医疗科技有限公司 | 一种基于机器视觉的注射针管自动检测系统和检测方法 |
| CA2976544A1 (en) | 2015-03-10 | 2016-09-15 | Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company | Multiple needle injector |
| JP7260898B2 (ja) | 2016-01-15 | 2023-04-19 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | ガンマデルタｔ細胞の活性化のための方法および組成物 |
| US10137144B2 (en) | 2016-01-15 | 2018-11-27 | American Gene Technologies International Inc. | Methods and compositions for the activation of gamma-delta T-cells |
| CN105671082B (zh) * | 2016-01-18 | 2020-08-07 | 武汉淼灵生物科技有限公司 | 一种表达外泌体标记物的慢病毒载体及其构建方法和应用 |
| EP3426777B1 (en) | 2016-03-09 | 2022-02-16 | American Gene Technologies International Inc. | Combination vectors and methods for treating cancer |
| CN109310827B (zh) | 2016-04-08 | 2021-09-07 | 阿勒根公司 | 抽吸和注射装置 |
| USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
| CA3082568A1 (en) * | 2017-11-15 | 2019-05-23 | Alcyone Lifesciences, Inc. | Therapy specific, pre-programmed auto injection device |
| WO2020013125A1 (ja) | 2018-07-09 | 2020-01-16 | 学校法人慶應義塾 | 注入器具セット |
| EP3876952A4 (en) | 2018-11-05 | 2022-08-24 | American Gene Technologies International Inc. | VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA |
| CA3151433C (en) * | 2019-09-27 | 2023-05-16 | Virginia Commonwealth University | Compositions and methods for restoring or increasing tissue perfusion |
| EP4048347A4 (en) * | 2019-10-22 | 2024-01-10 | Georgia Tech Research Corporation | METHOD OF PRODUCTION USING ADJUSTMENT OF SOLUBILITY OF COMPONENTS IN MICRONEEDLE CASTING FORMULATIONS |
| NL2024277B1 (en) * | 2019-11-21 | 2021-08-11 | Imcomet B V | Interstitial fluid removal device |
| USD933205S1 (en) * | 2020-02-28 | 2021-10-12 | Jeisys Medical Inc. | Needle array |
| CN112452365B (zh) * | 2020-11-23 | 2021-12-07 | 无锡市夸克微智造科技有限责任公司 | 微加工流体装置 |
| US11938087B2 (en) * | 2021-08-23 | 2024-03-26 | Young Hei Lee | Intramuscular stimulation needling device |
| GB2612576B (en) * | 2021-10-28 | 2025-02-26 | Active Needle Tech Ltd | Injection device |
| CN114569798B (zh) * | 2022-02-22 | 2023-03-28 | 湖南华耀百奥医疗科技有限公司 | 一种多孔植入物及其制备方法和应用 |
| CN115321499B (zh) * | 2022-08-11 | 2023-10-13 | 哈尔滨理工大学 | 一种用于生物成像的黑磷纳米片复合材料的制备 |
| US20250064336A1 (en) * | 2023-08-24 | 2025-02-27 | Johnson & Johnson Enterprise Innovation Inc. | Tissue classification system for detecting cancerous cells |
| WO2025054607A1 (en) * | 2023-09-07 | 2025-03-13 | The Regents Of The University Of California | Compositions and methods for treating sarcopenia |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4164559A (en) | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
| US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| US5041538A (en) | 1987-08-28 | 1991-08-20 | The Salk Institute For Biological Studies | Mammalian follistatin |
| DE3875456T3 (de) | 1987-11-09 | 1998-06-10 | Becton Dickinson Co | Verfahren zur Analyse hämatopoietischer Zellen in einer Probe. |
| US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
| US5030002A (en) | 1989-08-11 | 1991-07-09 | Becton, Dickinson And Company | Method and apparatus for sorting particles with a moving catcher tube |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| IE76732B1 (en) | 1990-08-07 | 1997-11-05 | Becton Dickinson Co | One step test for absolute counts |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| CA2102784A1 (en) | 1992-03-11 | 1993-09-12 | Peng Liang | Identifying, isolating and cloning messenger rnas |
| US5565324A (en) | 1992-10-01 | 1996-10-15 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
| ES2216005T3 (es) | 1993-11-09 | 2004-10-16 | Targeted Genetics Corporation | Produccion de titulos elevados de vectores de aav recombinantes. |
| CA2176215C (en) | 1993-11-09 | 2007-06-26 | James P. Trempe | Stable cell lines capable of expressing the adeno-associated virus replication gene |
| US8795242B2 (en) * | 1994-05-13 | 2014-08-05 | Kensey Nash Corporation | Resorbable polymeric device for localized drug delivery |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| EP0796339A1 (en) | 1994-12-06 | 1997-09-24 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| US5751629A (en) | 1995-04-25 | 1998-05-12 | Irori | Remotely programmable matrices with memories |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| CA2625279A1 (en) | 1995-08-30 | 1997-03-06 | Genzyme Corporation | Chromatographic purification of adenovirus and aav |
| AU715543B2 (en) | 1995-09-08 | 2000-02-03 | Genzyme Corporation | Improved AAV vectors for gene therapy |
| EP0774464B1 (en) | 1995-10-17 | 2004-07-28 | Combichem, Inc. | A template for solution phase synthesis of combinatorial libraries |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| US5858351A (en) | 1996-01-18 | 1999-01-12 | Avigen, Inc. | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
| US5935788A (en) | 1996-06-25 | 1999-08-10 | Lifespan Biosciences, Inc. | Subtractive hybridization techniques for identifying differentially expressed and commonly expressed nucleic acid |
| ATE465267T1 (de) | 1996-09-06 | 2010-05-15 | Univ Pennsylvania | Rekombinante aav zur herstellung eines medikaments für die gentherapie von muskelzellen |
| US5798035A (en) | 1996-10-03 | 1998-08-25 | Pharmacopeia, Inc. | High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay |
| AU8921698A (en) | 1997-08-29 | 1999-03-16 | Human Genome Sciences, Inc. | Follistatin-3 |
| US6953662B2 (en) | 1997-08-29 | 2005-10-11 | Human Genome Sciences, Inc. | Follistatin-3 |
| AU758708B2 (en) | 1997-09-05 | 2003-03-27 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of recombinant AAV vectors |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| EP1021197B1 (en) * | 1997-10-10 | 2007-04-11 | The Regents of the University of California | Implants comprising combinations of allogeneic cells for use in cancer treatment |
| US5942420A (en) | 1997-11-17 | 1999-08-24 | Millennium Biotherapeutics, Inc. | Molecules of the follistatin-related protein family and uses therefor |
| US6129670A (en) * | 1997-11-24 | 2000-10-10 | Burdette Medical Systems | Real time brachytherapy spatial registration and visualization system |
| US20030022207A1 (en) | 1998-10-16 | 2003-01-30 | Solexa, Ltd. | Arrayed polynucleotides and their use in genome analysis |
| US6410013B1 (en) * | 1999-01-25 | 2002-06-25 | Musc Foundation For Research Development | Viral vectors for use in monitoring HIV drug resistance |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| US6689103B1 (en) * | 1999-05-07 | 2004-02-10 | Scimed Life System, Inc. | Injection array apparatus and method |
| US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
| US6582938B1 (en) | 2001-05-11 | 2003-06-24 | Affymetrix, Inc. | Amplification of nucleic acids |
| US6450937B1 (en) * | 1999-12-17 | 2002-09-17 | C. R. Bard, Inc. | Needle for implanting brachytherapy seeds |
| US6558361B1 (en) * | 2000-03-09 | 2003-05-06 | Nanopass Ltd. | Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems |
| US6478776B1 (en) * | 2000-04-05 | 2002-11-12 | Biocardia, Inc. | Implant delivery catheter system and methods for its use |
| US7850663B2 (en) * | 2001-01-12 | 2010-12-14 | Becton, Dickinson And Company | Medicament microdevice delivery system, cartridge and method of use |
| ES2393282T3 (es) * | 2001-09-12 | 2012-12-20 | Becton, Dickinson And Company | Dispositivo de pluma basado en microaguja para la administración de fármacos |
| US20060206950A1 (en) * | 2002-11-04 | 2006-09-14 | Kaelin William G Jr | In vivo imaging of e2f-fegulated bioluminescent proteins |
| US6896666B2 (en) * | 2002-11-08 | 2005-05-24 | Kochamba Family Trust | Cutaneous injection delivery under suction |
| WO2004078984A1 (en) * | 2003-03-05 | 2004-09-16 | Janssen Pharmaceutica N.V. | Animal model for the fast identification of pharmaceutical active compounds in vivo |
| AU2004251699A1 (en) * | 2003-06-04 | 2005-01-06 | Georgia Tech Research Corporation | Drilling microneedle device |
| KR20060038407A (ko) * | 2003-06-30 | 2006-05-03 | 알자 코포레이션 | 비휘발성 반대이온을 포함하는 코팅된 미세돌출부용 제제 |
| BRPI0415629A (pt) * | 2003-10-31 | 2006-12-12 | Alza Corp | aplicador auto-atuador para conjunto de microprojeções |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US20060024711A1 (en) | 2004-07-02 | 2006-02-02 | Helicos Biosciences Corporation | Methods for nucleic acid amplification and sequence determination |
| US20060024678A1 (en) | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
| WO2006015299A2 (en) * | 2004-07-30 | 2006-02-09 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
| US20080269666A1 (en) * | 2005-05-25 | 2008-10-30 | Georgia Tech Research Corporation | Microneedles and Methods for Microinfusion |
| US20070093748A1 (en) * | 2005-06-23 | 2007-04-26 | Medtronic Vascular, Inc. | Methods and systems for treating injured cardiac tissue |
| US20070038181A1 (en) * | 2005-08-09 | 2007-02-15 | Alexander Melamud | Method, system and device for delivering a substance to tissue |
| US8734823B2 (en) * | 2005-12-14 | 2014-05-27 | The Invention Science Fund I, Llc | Device including altered microorganisms, and methods and systems of use |
| US20070162110A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Bioabsorbable drug delivery devices |
| US7771741B2 (en) | 2006-05-01 | 2010-08-10 | Warsaw Orthopedic, Inc | Demineralized bone matrix devices |
| WO2007138098A2 (en) * | 2006-05-31 | 2007-12-06 | Projech Science To Technology, S.L. | Animal models of tumour metastasis and toxicity |
| BRPI0602640B8 (pt) * | 2006-07-06 | 2021-05-25 | Anhanguera Educacional Ltda | métodos de obtenção de penta-1,4-dien-3-onas e de cicloexanonas substituídas e derivados com propriedades antitumorais e antiparasitárias, processo para preparar 1,5-bis-(aril)-penta-1,4-dien-3-onas alquiladas e aciladas, processo para preparar 4-nitro-3,5-diaril-cicloexanonas substituídas, processo para preparar 2,6-dibenzilideno-4-nitro-3,5-diaril-cicloexanonas substituídas, processo para preparar uma mistura formada por quantidades determinadas dos compostos (1,5-bis(4-hidróxi-3-metóxi-fenil)penta-1,4-dien-3-ona) e (1,5-bis(3-metóxi-4-acetóxi-fenil)penta-1,4-dien-3-ona), compostos e seus usos, composição farmacêutica, método terapêutico para tratamento dos cânceres e composição sinérgica |
| US20090270834A1 (en) * | 2006-08-21 | 2009-10-29 | Koninklijke Philips Electronics N.V. | Drug delivery device |
| CN101553275A (zh) * | 2006-08-29 | 2009-10-07 | 纳生微电子有限公司 | 用于活性物质透皮递送和取样的高纵横比微器件和方法 |
| US20080140026A1 (en) * | 2006-12-11 | 2008-06-12 | Sliwa John W | Acoustically-Aided and/or gel-aided delivery of beneficial gaseous, ionic, unstable, metastable, short-lived or reactive species for medical purposes |
| US20100196439A1 (en) * | 2006-12-22 | 2010-08-05 | Medtronic, Inc. | Angiogenesis Mechanism and Method, and Implantable Device |
| US20080214987A1 (en) * | 2006-12-22 | 2008-09-04 | Nanomed Devices, Inc. | Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances |
| JP2010532701A (ja) * | 2007-07-06 | 2010-10-14 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 調整可能な細孔容積を有する埋め込み型医療装置および該装置を製造するための方法 |
| SG183726A1 (en) * | 2007-08-14 | 2012-09-27 | Hutchinson Fred Cancer Res | Needle array assembly and method for delivering therapeutic agents |
| US20090093871A1 (en) * | 2007-10-08 | 2009-04-09 | Medtronic Vascular, Inc. | Medical Implant With Internal Drug Delivery System |
| JP5798918B2 (ja) * | 2008-08-21 | 2015-10-21 | ナインポイント メディカル， インコーポレイテッド | 薬物評価および局所処置のためのデバイスおよび方法 |
| EP2370115B1 (en) * | 2008-12-04 | 2016-08-03 | Technion Research & Development Foundation Ltd. | Hydrogel sponges, methods of producing them and uses thereof |
| US9408542B1 (en) | 2010-07-22 | 2016-08-09 | Masimo Corporation | Non-invasive blood pressure measurement system |
| TWI497333B (zh) | 2011-06-14 | 2015-08-21 | Giant Mfg Co Ltd | 自行車適配產生方法、自行車適配系統與電腦程式產品 |
| US9104666B2 (en) | 2012-09-04 | 2015-08-11 | Oracle International Corporation | Controlling access to a large number of electronic resources |
-
2011
- 2011-11-23 CN CN201180065642.4A patent/CN103492016A/zh active Pending
- 2011-11-23 JP JP2013541061A patent/JP2013544600A/ja active Pending
- 2011-11-23 EP EP14166779.0A patent/EP2767298A3/en not_active Withdrawn
- 2011-11-23 EP EP11843742.5A patent/EP2643045A4/en not_active Withdrawn
- 2011-11-23 US US13/637,274 patent/US20140114279A1/en not_active Abandoned
- 2011-11-23 AU AU2011332815A patent/AU2011332815A1/en not_active Abandoned
- 2011-11-23 CA CA2816883A patent/CA2816883A1/en not_active Abandoned
- 2011-11-23 CN CN201810705618.6A patent/CN108744262A/zh active Pending
- 2011-11-23 WO PCT/US2011/062128 patent/WO2012071559A2/en not_active Ceased
-
2013
- 2013-12-05 US US14/097,629 patent/US20140170072A1/en not_active Abandoned
-
2017
- 2017-01-13 JP JP2017003763A patent/JP2017109112A/ja active Pending
- 2017-11-13 US US15/811,636 patent/US20180256754A1/en not_active Abandoned
-
2020
- 2020-10-15 US US17/071,707 patent/US20210170052A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016101069A1 (en) * | 2014-12-23 | 2016-06-30 | Atkinson Cole Michael Joseph | Multiple needle assembly |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2643045A2 (en) | 2013-10-02 |
| US20140114279A1 (en) | 2014-04-24 |
| WO2012071559A3 (en) | 2012-07-26 |
| US20140170072A1 (en) | 2014-06-19 |
| JP2013544600A (ja) | 2013-12-19 |
| CN103492016A (zh) | 2014-01-01 |
| WO2012071559A2 (en) | 2012-05-31 |
| AU2011332815A1 (en) | 2013-05-30 |
| EP2767298A2 (en) | 2014-08-20 |
| US20210170052A1 (en) | 2021-06-10 |
| US20180256754A1 (en) | 2018-09-13 |
| JP2017109112A (ja) | 2017-06-22 |
| EP2767298A3 (en) | 2014-10-01 |
| EP2643045A4 (en) | 2016-01-13 |
| CN108744262A (zh) | 2018-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210170052A1 (en) | Therapeutic methods and compositions for solid delivery | |
| US20130280755A1 (en) | Therapeutic methods for solid delivery | |
| Roy et al. | Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques | |
| Wiltgen et al. | The hippocampus plays a selective role in the retrieval of detailed contextual memories | |
| Debattisti et al. | Dysregulation of mitochondrial Ca2+ uptake and sarcolemma repair underlie muscle weakness and wasting in patients and mice lacking MICU1 | |
| Babaeijandaghi et al. | Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics | |
| Girolamo et al. | Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice | |
| Li et al. | Imaging of macrophage mitochondria dynamics in vivo reveals cellular activation phenotype for diagnosis | |
| Zhou et al. | Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice | |
| Cui et al. | Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward | |
| Taylor et al. | Microglia disrupt mesolimbic reward circuitry in chronic pain | |
| You et al. | A role for conditioned ventral tegmental glutamate release in cocaine seeking | |
| US20200308550A1 (en) | Tumor organoid model | |
| Novak et al. | Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle | |
| Pierno et al. | Role of tumour necrosis factor α, but not of cyclo‐oxygenase‐2‐derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach | |
| Ki et al. | Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors | |
| Tayler et al. | Characterization of NMDAR-independent learning in the hippocampus | |
| Nagaoka et al. | Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia | |
| AU2004238057B2 (en) | CNS chloride modulation and uses thereof | |
| Packer et al. | Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration | |
| Blandin et al. | ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma | |
| Boyle et al. | The ventral CA2 region of the hippocampus and its differential contributions to social memory and social aggression | |
| Stitelman et al. | Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector | |
| Mannangatti et al. | Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference | |
| US20230109491A1 (en) | Edb-fn as biomarker of cancer and/or brain disease and nanodrug delivery system targeting same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20161104 |
|
| FZDE | Discontinued |
Effective date: 20190319 |